Author: Dani

2026 marks ten years since medicinal cannabis was legalised in Australia. To reflect on how far the industry has come, and where it’s headed next, we’re speaking with the people helping shape it. From early advocates, to scientific leaders working behind the scenes, this series captures the journeys, lessons, and hopes defining the first, and the next, decade of medicinal cannabis.

About Natalie D’Alessandro

Natalie D’Alessandro is a patient advocate and the founder of Viz Medicinal, where she supports practitioners and industry leaders to better understand the patient experience and approach medicinal cannabis with greater ethical care. 

She holds a Bachelor of Commerce and an MBA, and has completed executive education at Harvard and Wharton, bringing a strong commercial and governance lens to her work. Natalie has spent time working alongside cannabis communities across the USA, Mexico, Canada and Europe, experiences that continue to shape her culturally informed perspective. She also serves on the board of a Human Research and Ethics Committee, and is particularly focused on addressing stigma, advancing gender health research, and embedding values-led thinking into healthcare systems.

The Australian medicinal cannabis community is ten years young. How did you first find your way into this space?

I did whatever it took to get into the medicinal cannabis industry at ground level. I started by answering phones in a clinic where I learned that I absolutely love interacting with patients. Listening to patients, day-in-day out was a profound experience. It changed everything for me.

I moved from the clinic into digital education, always led by the same instinct: when something important needs to be done, I do it.

I approach my work as a creative practice. I’ve learned that my best work comes when I balance structure with play; much like my relationship with the plant herself.

I work with companies, practitioners and individuals who share the same values and want to deeply understand the patient experience. My focus is ethical and differentiated strategies that honour patients as informed participants in their own healthcare journey.

What is the most meaningful lesson you’ve learnt about the cannabis plant?

Values matter so much in this space. Working with values in alignment changes everything about how the work feels for me. 

Not everyone is ready for the same conversation at the same time, and that’s okay. We don’t need consensus to speak truthfully about our personal experiences. In fact, medicine depends on us valuing individual response rather than uniformity. 

Cannabis grows everywhere and has been used across cultures for millennia. Its prohibition and its return mirror broader social cycles, particularly women reclaiming voice and agency.

What sounds “woo-woo” at first often becomes practical once you’ve lived it. Speak to your body. Listen to your body. What? Weird. Wait a minute… What did my body just say?

At its best, cannabis acts as a mirror and a magnifier. At worst, cannabis also acts as a mirror and a magnifier, take from that what you will!

What three words capture your hopes for cannabis in Australia over the next ten years? 

Potent. Home. Remedy.

To learn more about Natalie’s ongoing community advocacy, follow Viz Medicinal on Instagram.  

The views, opinions, and statements expressed in this article are solely those of the individual contributor and do not represent, and should not be attributed to, Astrid. Astrid makes no claims. Contributors are not our patients – their experiences are shared with the sole intent to inform their inspiration behind driving change in the sector through their advocacy, research, or policy contributions.

2026 marks ten years since medicinal cannabis was legalised in Australia. To reflect on how far the industry has come, and where it’s headed next, we’re speaking with the people helping shape it. From early advocates, to scientific leaders working behind the scenes, this series captures the journeys, lessons, and hopes defining the first, and the next, decade of medicinal cannabis.

About Chad Walkaden

Chad Walkaden is the CEO and Founder of OnTracka, an Australian digital health company delivering compliant infrastructure for remote patient monitoring and real-world evidence generation across highly regulated therapeutic areas, including supporting international randomised clinical trials alongside TGA-aligned research programs in Australia. 

Chad has also led academic collaborations focused on translating structured real-world data into evidence that clinicians and regulators can rely on, including research in PTSD and psychedelic-assisted therapies, as well as the first structured dataset examining natural medicine use within Aboriginal and Torres Strait Islander communities.

A Stage IV cancer survivor, Chad brings lived experience to his work, alongside a career focused on building evidence-led systems that clinicians, researchers, and regulators can trust.

The Australian medicinal cannabis community is ten years young. How did you first find your way into this space?

In 2014, my journey in the medicinal cannabis community started when I was diagnosed with Terminal Stage IV Cancer. Surprisingly, my earliest introduction to the community was one of hesitancy and caution. Legalities aside, my belief systems were informed by a strong sense of criticism about the paranoia or cognitive deficits that may result from consuming cannabis. Consequently, I went through over a year of daily chemotherapy without any medicinal cannabis added into my life.

One day in 2015, the cancer returned more aggressively and spread to other parts of my body.On this day, at the very moment of walking out of the consulting room, a clear, memorable, and conscious thought passed through my mind. Those words were “why not try it”. 

Four years on, in 2019, OnTracka was founded in response to a series of observations made over more than five years while working closely across healthcare, research, and emerging treatment pathways.

During that time, it became clear that laws governing medicinal cannabis were shifting globally and domestically, creating new legal access pathways for patients. Jurisdictions such as California were often cited as early examples of this change. However, what stood out was that much of the momentum behind these reforms was driven by anecdotal accounts rather than structured clinical evidence.

This raised a fundamental question: how can clinicians responsibly engage with an emerging treatment area without access to consistent, real-world data that supports clinical decision-making? If prescribing is to sit within mainstream healthcare, it must be supported by evidence, transparency, and systems that clinicians can trust.

That question ultimately led to the creation of OnTracka. 

From the beginning, the focus at OnTracka was not on promotion or advocacy. But, on building infrastructure that could support high-quality research and structured real-world evidence generation. We believed that medicinal cannabis could play a meaningful role in the future of healthcare, but only if it was supported by data rather than stories alone.

What is the most meaningful lesson the cannabis plant has taught you?

The biggest learning has been patience. The plant was patient with me, and I’m patient with healthcare.

Healthcare does not change quickly, and neither do clinical behaviours or regulatory frameworks. We are living through a broader shift in how evidence is generated, how patients engage with care, and how emerging therapies are evaluated. Recognising this has reinforced the importance of long-term thinking, measured progress, and resisting the temptation to rush outcomes before the foundations are in place.

What three words capture your hopes for cannabis in Australia over the next ten years? 

First-line treatment. 

If you want a reliable, anonymous way to self-monitor progress, symptoms, wearable data, and dosing sessions, download the OnTracka app to stay across your medicines, mental health, and more.

The views, opinions, and statements expressed in this article are solely those of the individual contributor and do not represent, and should not be attributed to, Astrid. Astrid makes no claims. Contributors are not our patients – their experiences are shared with the sole intent to inform their inspiration behind driving change in the sector through their advocacy, research, or policy contributions.

2026 marks ten years since medicinal cannabis was legalised in Australia. To reflect on how far the industry has come, and where it’s headed next, we’re speaking with the people helping shape it. From early advocates, to scientific leaders working behind the scenes, this series captures the journeys, lessons, and hopes defining the first, and the next, decade of medicinal cannabis.

About Justin Sinclair

Justin Sinclair is a researcher and pharmacognosist, and currently serves as Chief Scientific Officer within the Australian medicinal cannabis industry. He has been working with medicinal cannabis in Australia since its earliest regulatory reforms. Trained in pharmacognosy, he has spent more than twenty-five years studying medicinal plants and fungi, with a focus on how plant-based medicines can be used safely and responsibly in patient care.

Justin was appointed to the Scientific Advisory Board of United in Compassion in 2015, contributing to the advocacy work that played a pivotal role in changing Australia’s medicinal cannabis laws. He has since played an ongoing role in shaping scientific standards and professional education across the sector, including advisory work with Cannabis Clinicians Australia (CCA) and board involvement with the Australian Medicinal Cannabis Association (ACMA).

He is currently completing doctoral research at the NICM Health Research Institute at Western Sydney University, investigating medicinal cannabis for endometriosis. Alongside his research, Justin has published widely and has been deeply involved in medicinal cannabis education, delivering over 150 lectures to healthcare professionals, industry leaders, and patient communities across Australia and New Zealand.

The Australian medicinal cannabis community is ten years young. How did you first find your way into this space?

I met Dan and Lucy Haslam at the first United in Compassion (UIC) Australian Medicinal Cannabis Symposium in Tamworth in 2014. I was deeply inspired by what they wanted to achieve, and given my background in pharmacognosy, I volunteered to the cause. I was welcomed with open arms, and joined the scientific advisory board of UIC in January 2015. 

This commenced a rather arduous and curious adventure down the rabbit hole of advocacy, education, and lobbying Federal and State politicians that eventually led to Dan’s Law being passed, and the associated regulatory frameworks we find ourselves with today. I consider it a great privilege to have worked alongside such a passionate and determined group of people in those early days, and every day since.

What is the most meaningful lesson the cannabis plant has taught you?

Cannabis has taught me that medicine is not solely about chemistry or receptor targets, but must include the lived realities of people navigating imperfect systems and complex diseases. Whilst cannabis is not a panacea that can address everything, for some, it addresses what nothing else could… and that makes it a medicine worth fighting for.

What three words capture your hopes for cannabis in Australia over the next ten years? 

Understanding, integration, and collaboration

To learn more about Justin’s ongoing work, you can follow him on LinkedIn. 

The views, opinions, and statements expressed in this article are solely those of the individual contributor and do not represent, and should not be attributed to, Astrid. Astrid makes no claims. Contributors are not our patients – their experiences are shared with the sole intent to inform their inspiration behind driving change in the sector through their advocacy, research, or policy contributions.

2026 marks ten years since medicinal cannabis was legalised in Australia. To reflect on how far the industry has come, and where it’s headed next, we’re speaking with the people helping shape it. From early advocates, to scientific leaders working behind the scenes, this series captures the journeys, lessons, and hopes defining the first, and the next, decade of medicinal cannabis.

About Rachel Payne

Victorian MP Rachel Payne is not your usual politician. Raised in a working-class community in Newcastle, she comes from humble beginnings. She left home at sixteen and has firsthand experience with welfare, government, housing, and legal services. She earned a master’s in public policy, and had a rich and varied life before politics. She held administrative, leadership and policy roles at Centrelink, the Eros Association, and the Family Court of Australia, and toured the world as an acclaimed burlesque performer. Motivated by social justice and community wellbeing, Rachel joined the Legalise Cannabis Party to reform outdated cannabis laws and unlock Victoria’s economic, environmental, and taxation opportunities.

The Australian medicinal cannabis community is ten years young. How did you first find your way into this space?

I am in my 40’s and have been a cannabis consumer most of my adult life to help manage my pelvic pain and anxiety. 

I say “pelvic pain” because “period pain” really doesn’t cover the burden of conditions like endometriosis and similar. Pelvic pain is debilitating for me and many other women, and at times leads to days off work and significant life impacts.

In managing anxiety, it is interesting that we accept “wine o’clock”, but downplay cannabis for slowing down busy minds and stressed bodies. I consider this use medicinal too.

What is the most meaningful lesson you’ve learnt about the cannabis plant?

She is such a beautiful, gentle plant! She’s been used for millennia by wise women. She’s versatile; a medicine, social relaxant, building material, fabric (and more), and she’s low-impact on both the earth and humans. There is a reason so many cultures have had “peace pipes.” 

I have learned to really respect her.

What three words capture your hopes for cannabis in Australia over the next ten years? 

Common Sense and Reform

To learn more about Rachel’s work, you can visit her website, or follow her on Facebook, X, Instagram, or LinkedIn. 

The views, opinions, and statements expressed in this article are solely those of the individual contributor and do not represent, and should not be attributed to, Astrid. Astrid makes no claims. Contributors are not our patients – their experiences are shared with the sole intent to inform their inspiration behind driving change in the sector through their advocacy, research, or policy contributions.

2026 marks ten years since medicinal cannabis was legalised in Australia. To reflect on how far the industry has come, and where it’s headed next, we’re speaking with the people helping shape it. From early advocates, to scientific leaders working behind the scenes, this series captures the journeys, lessons, and hopes defining the first, and the next, decade of medicinal cannabis.

About Paul O’Donoghue

Paul O’Donoghue is an educator, podcaster, and medicinal cannabis patient whose work sits at the intersection of cannabis use and mental health. He began his career in the Canadian cannabis industry during the early years of federal legalisation, before returning to Australia to advocate for more thoughtful drug policy and improved patient journeys.

He founded Give & Toke, a podcast and brand aimed at reducing stigma and elevating conversations around cannabis. Through this platform, Paul elevates the voices of patients, clinicians, policymakers, and industry leaders, to encourage more honest, culturally aware discussions about cannabis use.

The Australian medicinal cannabis community is ten years young. How did you first find your way into this space?

I came to medicinal cannabis looking for answers.

Like a lot of people, my early relationship with cannabis existed in the grey space between stigma and self-discovery. When medicinal access became possible in Australia, it reframed the plant for me completely. It went from something you had to justify using, to something that could be used with intention, safety, and support.

Over time, that personal experience turned into curiosity, and then responsibility. I started Give & Toke as a way to normalise conversations that felt missing at the time; patient voices, culture, humour, and honesty. 

Today, I sit in a space where I work within and respect highly regulated frameworks while still advocating for patients, authenticity, and greater access. That balance has shaped my journey.

What is the most meaningful lesson the cannabis plant has taught you?

The most meaningful lesson I’ve learned is that cannabis is deeply personal. The same plant can be grounding for one person, overwhelming for another, and ineffective for someone else entirely. That taught me early on that cannabis isn’t about chasing strength or trends, but about understanding context, the person, the condition, the dose, the delivery method, and even the environment it’s used in.

It also taught me humility. Cannabis is not a panacea, but when it’s respected and used intentionally, it can be an incredibly supportive tool.

I hope we move beyond treating cannabis as either a miracle or a menace, and instead treat it as a legitimate therapeutic and/or social option that deserves thoughtful regulation, honest education, and compassion for the people using it.

What three words capture your hopes for cannabis in Australia over the next ten years? 

Access, trust and maturity.

To learn more about the work Paul is doing, you can follow Give & Toke on Instagram or see more online at giveandtoke.com.au. You can also shop Give & Toke accessories online at Astrid Alchemy. 

The views, opinions, and statements expressed in this article are solely those of the individual contributor and do not represent, and should not be attributed to, Astrid. Astrid makes no claims. Contributors are not our patients – their experiences are shared with the sole intent to inform their inspiration behind driving change in the sector through their advocacy, research, or policy contributions.

This year, we commemorate 10 years of the legalisation of cannabis in Australia for medicinal and scientific purposes. On the 24th of February 2016, the federal government passed laws amending the Narcotic Drugs Act to allow the legal growing and sale of medicinal cannabis in Australia, and now the rapid growth of the medicinal cannabis market had sales projected to hit over $1 billion by the end of last year.

Australia, like many other countries, has a long and colourful history relating to the criminalisation and enforcement of cannabis use and cultivation. Changes to attitudes surrounding cannabis in the 1990s saw less draconian approaches to personal possession and use, alongside various polls suggesting increasing support from the public for legalisation. Throughout the 2000s we saw legalisation of industrial hemp, and in 2012, the TGA approved the first cannabinoid based medication; an oral spray called Sativex for the relief of muscle spasticity associated with MS.

In 2014, retired registered nurse Lucy Haslam and her late son, Daniel, founded what is now Australia’s primary medicinal cannabis advocacy body, United in Compassion (UIC). Daniel Haslam was a bowel cancer patient who achieved significant relief of his symptoms through the use of cannabis, and through his story and the founding of UIC, the issue of medicinal cannabis was propelled into the mainstream public awareness of Australians. The work of Lucy and Daniel Haslam through UIC was instrumental in achieving the federal legislative changes in 2016 that we commemorate and celebrate this year. UIC remains at the forefront of promoting education around the clinical uses of cannabis in addition to continuing to campaign for improved access to what many consider to be very important medication.

Since 2022, there has been a consistent and rapid increase in the sales of medicinal cannabis products, from around 1.68 million units to 6.59 million units in 2024, as reported by the Penington Institute. Currently, there are no shortages in clinics prescribing cannabis, and pharmacies willing to dispense prescriptions for medicinal cannabis products are not as hard to find as they were just 5 years ago. Numbers from 2025 have shown no exponential growth in medicinal cannabis sales for the first time since 2022, perhaps demonstrating a plateau in patient demand, or an inability of our current systems to facilitate access to other potential patients.   

So I suppose, the question being asked now, is where to from here? No one can really say for sure. But what we do know is that medicinal cannabis has been legitimate medicine for enough people that word from the TGA is that it’s here to stay. 

In fact, last year the TGA put out a call-out to all players in the Australian medicinal cannabis industry to submit their ideas for how to manage medicinal cannabis moving forward. The TGA is still sifting through all the submissions and it might take some time to see what direction they decide to take, but in the spirit of what UIC is all about, I would love to see an ongoing commitment to those values, particularly removing barriers to access.

One major barrier to access that we have seen some progress with (but quite frankly, not enough) are the driving laws. In most of Australia, it is still illegal to drive with any THC in your system. Now, to clarify, this is not about impairment; it is purely about whether you have THC in your system, and THC is a compound that tends to linger well past the time when effects have worn off. 

This makes many people who rely on driving every day reluctant to try THC based products from fear of getting into trouble with the law. Just to put this in perspective, you could be under the influence of a variety of different legal medications that cause impairment and would not get into any trouble if drug tested by police. But you could get in trouble if you happened to have some medicinal cannabis the night before, even though you show no signs of impairment. I believe this discriminates against patients using medicinal cannabis and needs to be addressed if we want to increase access.

The other major barrier for access, which comes as no surprise, is cost. This one is tricky, and the issues are multi-faceted. Prices for medicinal cannabis consults and prescriptions have become a lot more affordable over the last couple of years, however, the decrease in pricing in the current market means the cost is elsewhere. Often free consultations are part of a vertically integrated supply model where the patient has no flexibility in where they get their medication, or any agency to make choices about their treatment. Cheaper medicinal cannabis products can sometimes mean reduced product quality. So, despite some costs coming down, clearly the current system is not equitable. Because cannabis is still unapproved by the TGA and is only available via the special access scheme, there are no protocols within the current system to allow for its subsidisation. Which is just another incentive to find a better way to manage medicinal cannabis in Australia.

Despite people like me in the industry often highlighting the flaws within the current system, the fact that we have had medicinal cannabis legalised for 10 years in Australia, and the number of lives that it has helped improve, is ultimately something to be proud of. 

Cannabis has been an important part of human society for centuries, and while we have been slow to understand its benefits in the modern era, the work that has been done in the last decade proves that we are capable of radical change for the betterment of society. We have accomplished a lot, but as pointed out, there is still much to be done because true equity is not about everyone getting the same care, but about everyone being able to access the care they need. 

I would like to officially announce that Chemist Warehouse has signed an agreement to acquire Astrid. With Chemist Warehouse’s backing, we are able to supercharge Astrid’s growth, meaning:

• We will make your medicines more accessible
• We can build more Astrid’s closer to you
• We can grow our clinical care teams
• We will continue to improve access, education and advocacy

These are things we simply couldn’t achieve at scale on our own.

Truth is, medicinal cannabis continues to be one of the most highly regulated and resource-intensive industries in Australia. To continue providing ethical, elevated care – and to expand that care to more patients – we needed a partner who understood our vision, and could support our growth.

I want to be clear: Astrid’s values are not changing. Our patient-first approach, our commitment to integrity, our advocacy – all of this remains at the heart of what we do.

This is our opportunity to break the stigma in a meaningful way: cannabis could become a more accepted medicine with scale, with visibility, with investment, and with a team that continues to advocate loudly and unapologetically on behalf of our patients.

I am grateful to remain as CEO and will continue to lead Astrid with the same purpose and responsibility I always have. Your care remains the priority. The heart of Astrid isn’t going anywhere.

What this means for our community

I understand why this news may be unexpected. Astrid is personal — to me, to our staff, and to many of you who have trusted us with your health and your stories. That trust means everything.

Astrid is still Astrid — with the same heart, the same standards, and the same commitment to doing things the right way.

Thank you for trusting us with your health — that trust is something I will always protect.

We’re staying true to who we are.

We’re just gaining the support to reach more people who may need us.

Warmest,
Lisa Nguyen
Founder & CEO, Astrid

Published 12/12/2025.

Now, Victoria’s Inquiry into Women’s Pain, the first of its kind in Australia, has made it official. The pain gap is real, and it’s costing women their health, livelihoods, and sense of trust in the system.

More than 13,000 women, girls and gender diverse people shared their experiences of living with pain. What emerged was both deeply personal and profoundly systemic. 

The invisible weight of pain

Ninety percent of respondents said they had experienced pain that lasted more than a year, with 54% experiencing it daily and 31% experiencing it constantly.

Conditions like endometriosis, fibromyalgia, migraines and musculoskeletal disorders were common, but the real through-line was exhaustion; physical, emotional, and financial.

Pain didn’t stay in one place. It spilled into work, relationships, hobbies, and mental health. Eighty-nine per cent said pain affected their psychological wellbeing. Fifty-nine per cent of respondents reported that pain affected their lifestyle and hobbies, 52% their intimate relationships, and 44% their work, studies, or volunteering. Many described fatigue, anxiety, and a constant sense of being on edge. Some compared it to living “in a bubble of hell.” And while the symptoms varied, the impact was universal: life, in one way or another, had become smaller.

It’s all in your head

The most frequent story shared was one of dismissal. Seventy-one per cent of women said they were ignored or minimised by healthcare professionals. Many were told their pain was “normal,” “hormonal,” or “psychosomatic.” For others, the message was subtler but just as damaging; a raised eyebrow, a rushed appointment, an unspoken doubt.

This pattern doesn’t exist in a vacuum. Medicine, as the report notes, was built largely on male biology. The result being diagnostic tools, treatment guidelines, and research that don’t reflect women’s realities. It’s why women wait longer for diagnoses, receive less pain relief than men in emergency departments, and are more likely to be prescribed antidepressants instead of investigations.

The cost of being believed

Even when women did find care that helped, it came at a price. Sixty-eight per cent said the cost of treatment was a barrier, with many spending thousands on specialists, surgeries, and therapies that weren’t covered by Medicare. Those in rural areas faced additional travel and time off work, while carers described the strain of supporting loved ones through years of uncertainty.

The report captures stories of people who emptied savings, paused careers, or were met with care that centred reproduction over relief. For some, the financial and emotional toll was so severe it shaped every decision that followed.

Silence is the real problem 

What makes this report powerful isn’t just the data. It’s the conversations it has started. They reveal that women’s pain is not rare or exaggerated, it’s under-researched, under-treated, and under-believed.

It shows how cultural biases around gender, weight, race, sexuality and disability compound into neglect. It shows that pain is not just a medical issue but a social one, influencing how women work, parent, rest, and participate in community life.

Most of all, it shows how change begins when people are finally asked to speak openly, and have the opportunity to be heard.

What have we learnt? 

The Inquiry distilled thousands of individual stories into five clear truths about the experience of women’s pain, and the systemic failures that perpetuate it.

1. Unmet healthcare needs

Most women who sought medical help for their pain didn’t get the support they needed. Dismissal and inadequate treatment are common, eroding confidence and trust in healthcare itself.

2. Gaps in research and representation

The lack of sex and gender-specific research continues to undermine pain management. When the data doesn’t reflect women’s realities, the diagnosis rarely does either.

3. Gender bias in healthcare

Bias still shapes how pain is perceived, prioritised, and treated. Cultural norms, stereotypes and language barriers mean women’s pain is more likely to be minimised or mistaken for something emotional instead of physical.

4. Barriers across communities

Not all women face the same challenges, but many face more than one. Women in regional and rural Victoria, Aboriginal and Torres Strait Islander women, LGBTIQA+ communities and women with disabilities encounter added layers of distance, cost, and discrimination when trying to access care.

5. A call for change

Above all, women want to be heard without bias or judgment. Pain is multifaceted and experienced by girls and women in many ways. Interventions are required on physical, psychological, and social levels to make a lasting difference for Victorian girls and women.

A collective turning point

The Inquiry signals more than awareness. It signals accountability, and the start of a new conversation that moves beyond surviving pain to understanding it. It’s a historic shift in Australian healthcare. For the first time, women’s pain has been recognised not as anecdotes, but as data: measurable, undeniable, and impossible to ignore. It reframes pain as a public health issue, not a personal burden, and demands that research, policy and clinical practice finally catch up.

At Astrid, we see this as a call to rebuild the system from the inside out. One rooted in representation, credible science, and care that treats women as the experts of their own bodies. Listening is the beginning. Belief, action, and structural change must follow.

Astrid’s submission focussed on building a medical system that protects patients when it comes to access, products and transparency. Our Senior Pharmacist Nour, who worked on Astrid’s submission, shares his views.

Medicinal cannabis has been legal in Australia since 2016, and according to the Penington Institute, Australians were spending approximately $402 million on medicinal cannabis in the first six months of 2024, almost double the 2022 figure of $235 million.  This surge in medicinal cannabis use has had the Australian Therapeutic Goods Administration revisit the current medicinal cannabis model and reach out to the wider cannabis industry about what improvements and changes can be made to the current model.

While we welcome the TGA’s consultation, and their readiness to work with health professionals to create a safer and more streamlined access model for medicinal patients, I would like to highlight that one of the key factors in creating a better medicinal system would be the introduction of a legalised and regulated adult-use market.  This would help differentiate cannabis users who perhaps do not need medical guidance and are more likely to be using cannabis recreationally.  This would not only free up resources to help manage medicinal cannabis better, it would also mean that doctors, pharmacists and nurses are not being inundated constantly to provide whatever new cannabis flower is being hyped on social media platforms every other week.

The reality of a legalised adult-use market in Australia is looking very unlikely in the near future and so we are going to have to contend with making the best of the system we currently have, and to that effect, Astrid Clinic and Dispensary have, along with many other professionals in the industry, submitted a submission for the TGA consultation.  

When medicinal cannabis was made legal and introduced to the Australian market, the TGA prioritised ease of access to the market for manufacturers and suppliers, but cannabis was made a controlled schedule 8 drug, available only via the TGA’s Special Access Scheme pathway.  This has created a space where the supply of cannabis is heavily regulated between prescribers and patients, but not nearly as much oversight when it comes to manufacturing and wholesale.  What we now have is a medicinal cannabis market with over 1500 different products with more than half of those being different strains and strengths of dried cannabis flower. 

Now, for those not familiar, the TGA’s Special Access Scheme is designed to give Australian citizens access to medications unapproved for use in Australia.  Generally, this was a pathway to access highly specialised drugs for very specific circumstances.  Sometimes experimental, but most times short term.  Having around 100 different strains of a product with the same concentration of the active ingredient (in this case, tetrahydrocannabinol or THC) does not in any way fill a missing therapeutic need.  If anything, the number of products far exceeds any perceived therapeutic benefit.

So as you can perhaps start to understand, even without seeing how this plays out in practice, is a pathway for access that is not in-line with how medicinal cannabis is being prescribed or used, and while it remains an unapproved medicine, the current special access scheme clearly no longer makes sense in this context anymore.  Hence, amongst our recommendations is the consideration of a more streamlined pathway specifically for medicinal cannabis to make ordering quicker and easier for pharmacies and patients.

You may be wondering, if there is no additional therapeutic need then how are there so many strains of flower coming onto the market almost every other week?  Currently, a loophole allows manufacturers without an import licence to use an existing wholesaler to sponsor them to bring products into the market, which means, anyone with a bit of capital can find suppliers locally or overseas, and start bringing products in.  These are often smaller companies, owned and operated by people who are not healthcare professionals and sometimes very obviously targeting a recreational market.  In some cases, there have been limited-edition products, or small batch grows which is an absolutely bizarre concept to exist for a prescribed medicine.  Our recommendation to the TGA is to remove this loophole, as the Therapeutic Goods Administration, they should be regulating necessary therapeutic goods not facilitating the import of unnecessary additions to an already flooded market.

Just to clarify, I would love nothing more than to see an adult use market with a plethora of products, but our market as it currently exists is a medical market and it should be treated as such.  If decriminalisation were to become a reality any time soon, then we would likely see our medicinal cannabis model struggle to stay afloat if no real work is done now to protect this medical stream of access for the future.  Penington’s report estimates the illicit cannabis market is worth $5 billion, suggesting many people are “self-medicating” (and have for years) but a large number of medicinal cannabis patients will always need the guidance and support of doctors and pharmacists, so it is imperative that what we have is protected and streamlined to ensure safety, quality and accessibility to patients who need it most.

Speaking of maintaining the integrity of the medical model, our last major recommendation was for all manufacturers of medicinal cannabis products to comply with standardised and consistent professional labeling practices.  This means making sure that these medicines look like medicines and have all the relevant clinical and safety information clear for patients to see.  Currently, there are products with fancy and overly colourful packaging that could be mistaken for a bag of lollies, which poses a big risk for parents with young children.  There are products with well designed, artistic boxes with cool little slogans on them but that is not what we expect medicine to look like, and manufacturers of prescription medications should not be promoting their products directly or indirectly.  However these suppliers are clearly trying to create an experience for customers who buy their products but the suitability of medication in Australia is meant to be decided by the doctors and pharmacists.  Then there are manufacturers who make all their products look identical, which makes separating products for pharmacists unnecessarily complicated and could increase the risk of dispensing errors.  And as you can imagine, with how relatively easy it is to bring a product to market, there are a slew of products with barely legible writing, missing barcodes and unclear information.

For medicinal cannabis to be taken seriously in the wider healthcare space these are all considerations that need to be made and standardised to hopefully not just remove the stigma still associated with using cannabis, but also to make access for the patients who need it more seamless and safe.  In the absence of an adult-use market, we believe it is imperative to solidify our medical market for the future and to help set a precedent for any other emerging natural therapies that may come.

Every woman’s experience is different, and while hormone replacement therapy (HRT) has long been a go-to treatment, it’s not suitable or appealing for everyone. Concerns about side effects, contraindications, or simply wanting alternatives have many women looking elsewhere. Increasingly, that search leads to medicinal cannabis.

What Research Shows So Far

Cannabis for menopause is a new frontier, and hard evidence is still limited. To date, there have been no large clinical trials specifically testing cannabis as a treatment for menopause symptoms. That means doctors don’t yet have definitive answers on efficacy, optimal dosing, or safety for this specific use. However, early research and surveys provide some insights. 

A Harvard-led study found nearly 80% of midlife women who used cannabis reported it helped with sleep or mood disturbances. In Canada, a 2023 survey showed one in three women over 35 were cannabis users, and that most were using it for medical reasons like sleep issues (65%), anxiety and mood (45%), or joint pain and muscular aches (33%). Encouragingly, almost three-quarters said cannabis was helpful for their symptoms.

These findings align with what we know biologically. Cannabinoids like THC and CBD interact with the body’s endocannabinoid system, which helps regulate mood, sleep, and temperature; areas directly affected during menopause. That said, there are no large clinical trials yet, so evidence remains limited.

Here in Australia, research is starting to close that gap. Western Sydney University’s NICM Health Research Institute and industry partner Cannim have launched the MenoCann study to explore medicinal cannabis for menopause symptoms. 60 women aged 45–65 will be prescribed medicinal cannabis for six months. The primary goal is to see if cannabis can improve sleep quality, with secondary measures including anxiety levels, frequency of hot flushes, mood/depression, cognitive function, and overall quality of life.

Astrid Health works with NICM on clinical trials for endometriosis, and supports their expansion into menopause research. Results from MenoCann will provide much-needed clarity for women and doctors alike.

Barriers and Stigma

Despite the growing interest, access to medicinal cannabis isn’t straightforward. Women are less likely than men to receive a medicinal cannabis prescription, and many don’t feel comfortable telling their doctors they use it. In one Canadian survey, most women consulted had not discussed their cannabis use with their healthcare providers. Cost is also often mentioned as a barrier for women seeking cannabis care. Because of these barriers, a concerning trend is that some women turn to illegal or unregulated markets to obtain cannabis, risking products with no quality control or dosing guidance. Others rely on friends or the internet for information, which isn’t always reliable.

Reducing stigma is essential. Whether someone is personally for or against cannabis, the reality is women are already using it. It’s crucial to bring these conversations into the clinic, where risks and benefits can be weighed alongside other treatments. 

How Do Medical Professionals Feel About It?

From a medical standpoint, the emerging theme is cautious optimism. On one hand, there’s hope that cannabis might offer relief for menopause symptoms. After all, many women are finding it helpful and some doctors see potential. On the other hand, there’s resistance because of the lack of formal study. 

Advocates argue that menopause care shouldn’t be limited to a single approach. Melanie Wentzel, who is involved in the NICM/Cannim study, remarked that it shouldn’t be “HRT or the highway” when it comes to menopause treatment. Women deserve to explore and understand all options, including medicinal cannabis, and make informed decisions about what works for them.

Cannabis shows promise for menopause symptoms, but experts emphasise it should be part of a broader plan, not a replacement for proven therapies like HRT. A balanced approach might mean combining conventional treatments with lifestyle changes, counselling, or, where appropriate, medicinal cannabis.

Looking Forward

Menopause is personal, and women deserve options. Cannabis may not yet be a mainstream recommendation, but ongoing research like MenoCann is an important step toward understanding where it fits.

This Menopause Awareness Month, Astrid Health is proud to support a more open, informed conversation about symptom relief. Women shouldn’t have to navigate menopause in silence. Whether relief comes from HRT, counselling, or emerging therapies like cannabis, the goal is the same: better support, better health, and a better quality of life. 

If you or someone you love is going through menopause, know that you’re not alone and that many avenues for relief, old and new, are being explored. Always consult with healthcare professionals when trying a new therapy, and stay tuned as science catches up with women’s real-life experiences. 

If you’re looking to explore integrative and holistic treatment options, book a free call with one of our friendly nurses today.

I pay my respects to First Nations elders, past, present and emerging, and as a healthcare professional dedicated to justice and fair access for all, I acknowledge that sovereignty has never been ceded, treaties have never been signed and I am honoured to work on what was, and always will be, Aboriginal land.

With NAIDOC Week celebrations being held across Australia, we discussed how our dispensary could get involved in recognising the history, culture and achievements of Aboriginal and Torres Strait Islander peoples. Since NAIDOC Week is an opportunity for all Australians to learn about First Nations cultures and histories, we, as a natural therapies clinic and dispensary have decided to dig into the history and tradition of Aboriginal plant use in what is often called ‘bush medicine’.

Bush medicine refers to ancient and traditional medicines used by Aboriginal and Torres Strait Islander people. Australian First Nations people have been using various components of native Australian flora and some fauna as medicine for millennia, and some still turn to healers in their communities for these natural medicines aimed at providing both physical and spiritual healing. While the use of bush medicine has declined, partly due to the loss of information, this can primarily be attributed to the ongoing effects of colonisation and policies made to eradicate Aboriginal peoples and their culture, such as the Stolen Generation. In Aboriginal culture, information is not passed on through writing, but through oral traditions, which means records do not last without a living culture. Without traditional ceremonies, this millennia of knowledge that Aboriginal elders hold could be lost.

Despite this, Professor Joanne Jamie, a medicinal chemist from Macquarie University, in Sydney, has managed to compile a database on Aboriginal plants and we have listed the most common Indigenous bush medicines as first summarised by Australian Geographic:

Tea tree oil (Melaleuca alternifolia)

The Bundjalung people from the New South Wales coast crushed tea-tree (or paper bark) leaves and applied the paste to wounds, as well as brewing it as a tea for throat ailments. In the 1920s, scientific experiments showed that the antiseptic potency of tea-tree oil was actually stronger than commonly used antiseptics of the time. Since then, the oil has been used to treat everything from acne to fungal infections.

Eucalyptus oil (Eucalyptus sp.)

Eucalyptus oil is perhaps one of the, if not the most commonly used, of the traditional Bush medicines. Eucalyptus leaves were often infused and used as a treatment for body aches and fevers. These days, Eucalyptus oil is commercially available in mouthwash, cough medicine and throat lozenges.

Kakadu plum/Billy goat plum (Terminalia ferdinandiana)

This native fruit from the woodlands of the Northern Territory and Western Australia is one of the world’s richest sources of Vitamin C. The plum has 50 times the Vitamin C of oranges, and was a major source of food for tribes in the areas where it grows. The Kakadu plum tree was also of great value as the inside of the bark was used for treating various skin ailments and infections. Currently, kakadu plums are being used as a food, preservative and even a cosmetic ingredient.

Desert mushrooms (Pycnoporus sp.)

This genus of mushrooms is distinguished from most others because of its bright red-orange colour. One would suck on the desert mushroom to cure a sore mouth or lips. It has been known to be a kind of natural teething ring, and was used for teething babies and babies with oral thrush.

Emu bush (Eremophila sp.)

Northern Territory tribes used preparations of emu bush leaves to wash sores and cuts and occasionally it was even used as a mouth gargle. In the last 10 years or so, leaves from the plant were found to have similar strengths as some commonly used antibiotics. Scientists in South Australia have expressed interest in experimenting with the plant for sterilising implants (e.g. artificial hips).

Witchetty (Witjuti) grub (Endoxyla leucomochla)

Witchetty (Witjuti) grubs are the larvae of a species of cossid moth that are endemic to Australia. Traditionally, a source of bush tucker, some communities in Central Australia also crushed witchetty grubs to make a paste and placed it on burns. The burn is then bandaged up to seal and soothe the skin.

Snake vine (Tinospora smilacina)

Tinospora smilacina is a woody vine, called Wararrkaji in Walmajarri. Central Australian communities used to crush sections of the vine to treat headaches, arthritis and other inflammatory conditions. The sap derived from the leaves was also used as a wound treatment.

Sandpaper fig (Ficus opposita) and stinking passion flower (Passiflora foetida)

Sandpaper figs are a species of fig native to the Northern Territory and Queensland. Interestingly enough, the stinking passion flower is not endemic to Australia and was introduced to parts of Northern Australia in 1880. Despite it being an invasive species, northern coastal communities used stinking passion flower in combination with sandpaper figs to relieve itching. Rough leaves of the sandpaper fig are crushed and soaked in water, then rubbed on the place of itching until it bleeds. The pulped fruit of the stinking passion flower is then spread onto the affected area. The leaves, and sometimes the sap, of the sandpaper fig have also been used to treat fungal infections of the skin, such as tinea.

Kangaroo apple (Solanum laciniatum and Solanum aviculare)

Kangaroo apple, also known as New Zealand nightshade, is a flowering plant species native to the East Coast of Australia and New Zealand. First Nations communities in Australia used the fruit as a dressing for swollen joints as the plant contains a steroid which helps in the production of cortisone. The unripe fruit was also traditionally boiled by some communities and used as an oral contraceptive for women.
The unripe fruit, and leaves of the kangaroo apple contain an alkaloid called solasodine. S. aviculare is now cultivated in Russia and Hungary for the solasidine, which is extracted and used in the production of steroid-based contraceptives.

Goat’s foot (Ipomoea pes-caprae)

Goat’s foot is common on the sand dunes of the upper north coast of New South Wales, and can also be found along the entire Queensland coastline. Communities from northern Australia and parts of New South Wales crushed and heated the leaves, then applied them directly to the skin for pain relief from sting ray and stone fish stings.

As we continue our work in health that celebrates the power of plants, it’s vital we acknowledge the deep well of knowledge held by Aboriginal and Torres Strait Islander communities. Bush medicine is not just a practice of the past. It’s a living, breathing tradition that deserves recognition, respect, and protection. This NAIDOC Week, may we listen more deeply, learn more openly, and honour the custodians of the oldest continuing culture on Earth.

For holistic health to live up to its name, it must account for the full picture: mental, emotional, physical, cultural, and spiritual wellbeing.

Across the world, treatments like Ayurveda, spiritual healing, and community-led care have long supported health in ways Western medicine is only beginning to acknowledge. When we make space for these diverse perspectives, we don’t just make health more inclusive, we make it more effective.

Strong social ties and cultural belonging are powerful predictors of health. It has been found that social isolation and loneliness are associated with a 29% and 26% increased risk of all-cause mortality, respectively. Meanwhile, studies on Indigenous and ethnic minority communities consistently show that a strong cultural identity is linked to better mental health and resilience, even in the face of structural disadvantage. 

Community and culture aren’t just social features; they’re health tools. They influence how people understand symptoms, access support, and navigate recovery. In many cultures, illness is seen as relational or spiritual, not just physical, and healing might involve prayer, ceremony, or traditional remedies alongside medical care.

Sri Lanka offers a compelling example of how traditional medicine coexists with modern care. Ayurveda is a holistic system of traditional Indian medicine that focuses on restoring balance in the mind, body, and spirit. The country’s Ayurvedic system is deeply embedded in public health: around 40–59% of the population regularly uses Ayurveda for everyday health needs. These practices are not “alternative”. They’re trusted, government-supported, and widely used. In rural communities, people often consult Ayurvedic practitioners for injuries, digestive issues, and chronic pain before seeking Western treatment.

Globally, the World Health Organization (WHO) reports that 170 countries, making up 88% of WHO Member States, acknowledge the use of traditional and complementary medicine in their national health systems, a testament to the cultural relevance of these practices. From acupuncture in China to curanderos in Latin America, people around the world seek care that reflects their beliefs, values, and context.

Rather than dismissing these systems, a growing movement within global health is calling for respectful integration. When traditional practices are combined with evidence-based care, and when patients feel seen in their cultural identity, outcomes often improve. Respect is a form of medicine, too.

Culture also shapes how people perceive mental health, and how willing they are to seek help. In Japan, societal values like endurance, privacy, and “saving face” have historically contributed to silence around psychological distress. Mental illness is still heavily stigmatised, and only around 6% of Japanese people have ever used counselling services, compared to more than 50% in countries like the US and UK. 

This reluctance has real consequences. Japan has a high suicide rate among developed nations, and issues like hikikomori (severe social withdrawal) remain widespread. But things are shifting. Data compiled by the Ministry of Health, Labor, and Welfare based on statistics from the National Police Agency shows there were 20,268 suicides in Japan in 2024. This was a decrease of 1,569 from the previous year and the second-lowest total since records began in 1978. New government suicide prevention policies, growing mental health education in schools, and a younger generation more open to therapy are beginning to move the dial.

The lesson? Mental health care isn’t just about access, it’s also about cultural framing. Messaging, language, and treatment approaches must reflect how people see the world. Without that, support can miss the mark.

Every year, the Nordic nations top the World Happiness Report. Countries like Finland, Denmark, and Norway consistently rank highest for life satisfaction, and they also boast strong public health outcomes, from long life expectancy to low mortality rates, especially from preventable and treatable causes.

What sets them apart is not just money. It’s a culture of trust, equality, and social support. These countries offer universal healthcare, generous parental leave, and policies that promote work-life balance. In Norway, for instance, the average workweek is between 27-34 hours, leaving more time for rest, relationships, and joy. 

Happiness itself has been linked to better immune function, lower inflammation, and longer life expectancy. But the takeaway isn’t that we all need to live like Scandinavians. It’s that health thrives where people feel secure, supported, and socially connected. And that looks different in every culture.

So what happens when healthcare ignores cultural context? People disengage. They delay care. They feel misunderstood, or worse, discriminated against.

Culturally responsive care isn’t just idealistic, it improves outcomes. Studies show that when providers reflect the communities they serve and adapt care to cultural needs, patient satisfaction and adherence increase. In Indigenous communities, working alongside traditional healers has improved health outcomes and trust in public health programs.

Representation matters at every level, from the clinic to the lab. When medical studies include diverse populations, treatments become more effective for more people. When practitioners speak your language or understand your worldview, care feels safer.

A holistic health system benefits everyone. Holistic health means seeing the whole person, and that includes their cultural, spiritual, and community roots. Wellness takes many forms. What unites them is a sense of connection: to self, to others, to place, and to tradition.

At Astrid Health, we believe that diversity is not a barrier to health, it’s the key to it. By listening deeply, making space for different ways of healing, and celebrating cultural knowledge, we can create a system where everyone sees themselves reflected in their care.

Health isn’t just what happens in a clinic. It’s what happens in a community. Follow @astrid.dispensary and see how we’re reimagining care — with heart, with purpose, with you.

At Astrid, our nursing team is a crucial part of how we support patients– combining clinical knowledge with practical, compassionate care. To mark the occasion, we sat down with one of our nurses to talk about their path into the profession, the realities of working in medicinal cannabis, and the moments that make it all worthwhile.

What inspired you to join the medicinal cannabis industry and in particular, Astrid? 

In my previous roles in surgical nursing, palliative care, and general practice, I often encountered patients who weren’t finding the relief they needed through conventional treatments alone. Having had similar experiences myself, I felt an even stronger drive to be part of a healthcare space that offers clinically supported alternative treatments. That’s what helped lead me to this industry and to Astrid – we provide an opportunity to support people more holistically. I’m especially passionate about challenging the stigma around natural therapies and helping both patients and clinicians feel more informed and confident through education and evidence-based care.

What do you love most about working at Astrid? What do you think sets Astrid apart from other clinics or dispensaries?

The balance between considered patient care and strong teamwork. At Astrid, we’re encouraged to think critically, share ideas openly, and take responsibility for our clinical decisions. It’s not about rushing to quick fixes – we take the time to do things properly. That same mindset flows into how we care for patients. We take the time to listen, communicate openly, and focus on what could help them feel better in the long run.

How has working at Astrid shaped your perspective on patient care?

It’s made me more aware of how important it is to meet patients where they are. Patients come to us with different levels of knowledge, comfort, or even skepticism about natural therapies. Offering guidance while creating a space where they feel comfortable to share their story and experiences has become an even more integral part of my approach to quality nursing care. Real impact comes not from just treating symptoms, but from guiding people toward taking better control of their health.

Book a free 10-minute nurse call with Liv here.

The smell of election (amongst other things) is in the air, and as always, voters re-visit the issues that are important to them.  As professionals working in the cannabis industry there is always a conversation about whether there is a case to be made for full-scale cannabis decriminalisation and legalisation in Australia and I honestly believe that this is unlikely to happen any time soon.

Some might argue that I am perhaps being a bit pessimistic, and that with loud enough voices we can see real change in the space.  While cannabis accessibility has improved, the current medical model is restrictive in a variety of ways, and one may argue, unnecessarily so.  For a certain segment of patients who may be more recreationally-inclined (for lack of a better term), the current model has effectively turned many doctors into dealers, and allowed for the creation of vertically integrated cannabis conglomerates who have exploited these restrictive frameworks to lock ‘patients’ into their ecosystems. 

This has essentially created a legal cannabis market, that is not ‘medicinal’ in the intended use of the word, with prescriptions instead just becoming the loophole to access cannabis.  So it would make sense to dispense with this charade and instead create a more honest and accessible framework for acquiring cannabis outside the evidently flawed so-called medical model.      

I get it, and I am all for it. I just do not think the conversation is going anywhere right now and any attempts to raise the above issues with policy makers is likely to fall on deaf ears (as it has time and time again).  We might have to put any hope for radical changes on hold simply because the current system, with all its flaws, is perhaps the most politically convenient way of managing cannabis in Australia right now.  For people who fought for its legalisation, it is legal with conditions, and as alluded to, easy enough to access.  For the more conservative voting block, it is still technically illegal without a prescription and so you have two opposing sides of the issue appeased.

Dumping the management of cannabis onto the Therapeutic Goods Administration and healthcare providers, means the politicians of the two major parties are free to deal with the issues that get them votes (like dropping the price of eggs) and hence why I do not see any time or effort going into the legalisation of cannabis any time soon.  Cannabis use in Australia is not as endemic to the culture as it is in the United States and we have to contend with the reality that it is not a big vote-grab issue for the ALP, and obviously not the LNP.  (This particular issue is actually a good case-study in highlighting the limitations of our two-party system at getting things done for the betterment of society as a whole, but that’s an opinion for another day).

I bring this up because people often ask us when we think cannabis will be fully legalised and I suppose I am trying to expand on the answer of ‘not any time soon’.  There are a number of activists and even dedicated parties who are vocal about this issue, and part of me maybe thinks that given the aforementioned reality of the situation then perhaps our energy could be focused elsewhere? 

Instead of advocating for what is being called ‘adult-use’ legalisation, perhaps we invest some time and effort into enhancing the current medicinal model we do have.  The amount of products currently on the Australian cannabis market far exceed any logical therapeutic need, so instead of new cannabis companies coming to market every month with fancy exotic strains or different flavoured gummies I would like to see investment in training community GPs about cannabis medicine.  There is so much positive feedback from patients after beginning medicinal cannabis, but they are forced to go through separate specialised clinics that do not know them, or are familiar with their history.  Instead of patients seeking out medicinal cannabis as an alternative to their current therapies, it would be ideal if their regular physician knew enough about it to prescribe it to them alongside their regular medication.  This not only ensures continuity of care, but also means patients will not need to pay extra to see doctors who only prescribe one type of medication.

If medicinal cannabis products get prescribed more regularly as part of doctors’ general practice then we not only safeguard the medical system for the future but also increase accessibility to more patients and reduce the monopolisation of online cannabis services who seem to put profits before patient care (because, to them they are not patients, but customers).  Training more doctors and pharmacists in medicinal cannabis ensures that if adult-use legalisation does occur, then we have the healthcare professionals who will maintain a viable medicinal stream for patients who would rather not purchase through an adult-use market.  Furthermore, it would help build and establish the infrastructure for non-biased cannabis education that would help inform future regulation.  Legalisation now though, would likely see a mass exodus of actual health professionals from the cannabis space and perhaps inadequate care for people who genuinely depend on this medicine for their livelihoods and require the guidance of doctors, pharmacists and nurses.

So again, if you ask me if I am supportive of legalisation, yes I clearly am.  However the political reality in Australia right now means this is not going to happen any time soon and I think we need to take this chance to more widely position cannabis medicine as not just an alternative, but a mainstream therapy that can be prescribed and accessed concurrently with patients’ other therapies.

Read Lisa’s opinion piece here.

Change rarely happens overnight. But it does happen when we believe in it enough to start. 

Lucy Haslam changed Australian law because she refused to accept the status quo. She believed in a better system for patients, she pushed the conversation forward, and she helped legalise medicinal cannabis in Australia.

The next steps—expanding access, building trust within the medical community, and strengthening the role of plant medicine in mainstream healthcare—require the same hope and persistence that Lucy Haslam showed.

At Astrid, we hold onto that same belief in change. As its founder, I believe in legalisation of adult-use cannabis. I believe it will happen in the coming years. And I believe it can and should co-exist with a medicinal market.

Of course, the path ahead won’t be easy. There’s no denying that cannabis reform faces major political hurdles. The two-party system does not currently prioritise cannabis legalisation, and the path ahead will be slow and complex. But if we only look at today’s political landscape, we miss the bigger picture: it’s not just about this election. It’s about the next decade. 

Change doesn’t start with Parliament. It starts with people, then policy, then progress. Without hope, conversations, and action at every level, nothing moves. This is why advocacy matters, and why Astrid will always be part of those conversations. 

While full adult-use legalisation may not happen this year, the momentum is undeniable—and the signs of progress are everywhere.

In 2024, Astrid was honoured to present evidence to the Senate during the Greens’ cannabis legalisation bill discussions — a powerful reminder that our voice, and our patients’ voices, are being heard at the highest levels of government.

Beyond the Senate floor, the broader movement is only growing stronger. The Legalise Cannabis Party is larger, more organised, and more visible than ever, running candidates across the country and pushing real healthcare reform onto the political agenda.

Across the industry, there is also widespread support for leaders like Fiona Patten, who are championing improvements to medicinal cannabis access and calling for federal Senate enquiries into smarter, evidence-based regulation.

This election may not deliver everything at once. But it can send a clear message: cannabis reform is no longer a fringe issue. It’s growing. It’s gaining momentum. And it’s only getting louder.

At Astrid, we are proud to be part of this progress—but our focus remains where it always has been: on our community. Astrid is not a political organisation. We are patient-led and community-driven. We work closely with policymakers, advocacy groups, and health professionals to make sure our community’s needs are represented at every level. 

Our community wants better access.

Our community supports smarter regulation.

Our community deserves to be heard.

And when our community’s needs align with political movements like the Legalise Cannabis Party, we stand alongside them in advocacy.

If we keep showing up, advocating, and believing in better, Australia’s cannabis future could look very different by 2030. Here’s what I envision for a Dual Medical and Adult-Use Cannabis Market, with some key data from Penington Institute’s Cannabis in Australia 2024 Report:

1. Respecting Medical Integrity and Patient Needs: Medical cannabis users often have specific needs — clinical care, standardised dosages, pharmacist support. A separate, well-regulated medicinal cannabis program ensures that patients can access the right products under clinical guidance, without being lumped into the broader recreational system. In the first half of 2024 alone, Australians purchased 2.87 million units of medicinal cannabis—almost double the previous half-year figure—demonstrating just how critical and fast-growing this system is.

2. Expanding Access and Reducing Stigma: Adult-use legalisation removes the gatekeeping of access and helps destigmatise cannabis use. Many people who use cannabis for wellness — managing sleep, anxiety, or minor pain — may not want to go through the formal medical system. Adult-use legalisation empowers personal choice while encouraging responsible use. An estimated 700,000 Australians used cannabis for medical reasons in the past year, but only around 200,000 accessed it via prescription—showing a gap in access that adult-use reform could help address.​

3. Preventing Industry Monopolisation and Promoting Innovation: Opening an adult-use market can drive competition and improve affordability for all users. Medicinal-only markets can consolidate power; in 2023, 76% of medicinal cannabis sold was dried flower, while nearly 81% of imports came from Canada—highlighting the need for local innovation and broader access options.

4. Boosting Economic Growth and Tax Revenue: Regulated cannabis markets overseas generate billions in revenue. Australia’s $5 billion illicit market—currently controlled by criminal networks—could be redirected into health, education, addiction services, and community development. Economists estimate that legalising cannabis could convert this massive black market into a regulated, taxable industry.​

5. Enhancing Public Health and Safety: Regulation means oversight, testing, and consumer education. Australia spends an estimated $2.1 billion per year on cannabis law enforcement, with 90% of arrests targeting users—not suppliers. A regulated market can shift this focus toward harm reduction and safety.

6. Reflecting the Reality of Cannabis Use: Nearly half of all Australians have used cannabis. Legal frameworks should reflect lived realities—not criminalise them. 42.3% of adults report lifetime cannabis use, and 2.4 million used it in the past year. Legalisation isn’t radical—it’s a realistic response to how people already live.​

This future won’t build itself. It will take patience. Persistence. And powerful conversations that don’t stop after election day. True change isn’t only won at the ballot box, but the ballot box can be the beginning.

Even if full legalisation isn’t imminent, keeping cannabis on the agenda is essential. Every conversation matters. Every piece of advocacy matters. And together, I have high hopes that we can help shape a better future for cannabis care in Australia by advocating now, and beyond this election season. 

Read Nour’s opinion piece here.

In the weeks and months leading up to the election, The Legalise Cannabis Party MPs and candidates have been door knocking and speaking up louder than ever before to ensure they place a desired number on your ballot paper.

Election years come with an abundance of promises, policies and opinions. So we asked our Pharmacist Nour and Founder Lisa to share their opinions on the likelihood of legalisation of cannabis in this year’s election.

High Hopes or Delusion?  The Reality of Cannabis Legalisation in Australia.

Read Nour’s full piece here.

Hope Is Not a Fantasy. It’s A Force. 

Read Lisa’s full piece here.

Dr Thomas Arkell (BA, PhD) is a researcher in the field of psychopharmacology. Based at Swinburne University’s Centre for Mental Health and Brain Sciences, he is an NHMRC Emerging Leadership Fellow, focused on understanding how cannabis affects the brain and human behaviour, with particular interest in its impact on cognition, driving ability, and day-to-day functioning. 

Alongside his research, Dr Arkell works closely with patients to explore the therapeutic potential of medicinal cannabis. His work is informed by a broader interest in the behavioural effects of psychoactive substances, including previous studies involving MDMA and alcohol.

Dr Arkell is part of the team leading the world-first Victorian Drug Driving Trial, a historic study commissioned by the Victorian Government. Swinburne University has been appointed the official research partner for the trial, which is the first of its kind in Australia to examine how medicinal cannabis affects driving performance under real-world conditions.

We invited the Astrid community to share their questions about the trial, then sat down with Dr Arkell to help answer them.

What motivated this trial, and what kind of change could it create for people using medicinal cannabis?

The Victorian Government is aware of the fact that more and more patients are using medicinal cannabis, and that the restriction on driving is an issue for them. The motivation for conducting the trial is to better understand whether Victorians who are prescribed medicinal cannabis (containing THC) can be in control of a vehicle without compromising their safety, or the safety of other road users.

The trial has been delayed multiple times between both the Andrews and Allan Governments. Are we on track to see results by the end of 2025, or is 2026 more realistic? 

We estimate the study will take around 18 months from the first drive. Once the study is completed, we will provide the results to the Department of Transport and Planning. The next steps are up to the Victorian Government. For more information about the trial and to keep updated as the trial progresses, you can go to our study website. 

How many participants are involved in the trial, and how were they selected? Is there diversity across gender, age, medical conditions, and dosage formats in the trial? 

The trial will involve 72 participants who will each complete several days of testing involving comprehensive assessments of driving performance, cognitive function, and a broad range of other measures, including blood and saliva samples and various questionnaires. The trial is enrolling an even number of males and females, an even number of people using oral and inhaled products, and an even number of people using medicinal cannabis for chronic pain, anxiety, and for sleep disorders. We have designed the trial to make it as representative and inclusive as possible. 

Why was a minimum dose of 2mg THC set for trial participants? 

This is to ensure the results are relevant to medicinal cannabis products that could theoretically impact driving performance. We wished to exclude CBD-only products that can still contain fractional amounts of THC but are not considered to be impairing.

Do you believe the results of this trial could influence cannabis-driving law reform in other states across Australia?

Our role is simply to undertake the study to the highest possible scientific standard and report back to the Government. We expect that other states will be interested in the results of the trial.

The work towards progressing cannabis as a more accepted medicine is welcomed. Do you know of any trials on the horizon that may need participants?

There are several trials happening across the country at the moment. Your best resource for this information is the Australian New Zealand Clinical Trials Registry which is where researchers are required to register their trials.

You will also find more information about our on-track driving trial on this page under the heading ‘An On-track Trial to Assess Driving from Medical Cannabis’.

As access to medicinal cannabis continues to grow, so too does the need for clear, research-backed guidance around its use – especially when it comes to driving and day-to-day safety. Trials like this mark an important step forward in shaping policy that reflects both science and lived experience.

We’re grateful to Dr Arkell for sharing his insights, and to our community for continuing to ask thoughtful, important questions. At Astrid, we remain committed to supporting informed, safe, and empowered choices in plant-based care.

To stay updated on the Victorian Drug Driving Trial, please visit the study website.

While popular culture has normalised (to some extent) the idea of edibles, the current medicinal market in Australia is still heavily geared towards cannabis flower and oils. The last year has seen a massive growth in medicinal cannabis edibles, and as always, we are here to break down the options, alongside the pros and cons of going edible.

To clarify, edibles in this context are not brownies, or the infamous Amsterdam space cake, or those hash cookies your obscure uncle bakes in an electric oven from his caravan in the bush. Medicinal cannabis edibles refer to medicinal cannabis products that have been designed and formulated to be taken orally and digested or absorbed under the tongue. Medicinal cannabis edibles exist currently in 2 forms in Australia, as sublingual wafers, and pastilles – more commonly known as gummies. 

Sublingual wafers are powdery tablet shaped edibles that are designed to dissolve under the tongue. Their advantage over pastilles is that they do not need to be chewed and so may be easier to take for patients who have trouble with solids and because some absorption occurs under the tongue, their onset of effect may be quicker than other edible forms.

Pastilles, or gummies, are, as the name suggests, soft and chewable flavoured products. In addition to the flavouring, gummies are also sweetened and the active ingredients (mostly THC and/or CBD) are evenly dispersed within a gelatin or pectin core that helps to mask the cannabis aftertaste making them a lot more palatable than other forms of cannabis medicine.

So, now the question remains, why go for an edible form of medicinal cannabis?

• Discreet: Cannabis gummies do not look like medicine and can be carried around anywhere. Patients can take their medication without fear of being asked what and why they are using it.
  
• Odourless: Unlike cannabis flower, or vape cartridges, there is no cannabis smell with gummies, which adds to their discretion and makes them easier to store and carry around, even in public.
  
• Convenient and device free: Once the suitable dose is achieved, there is nothing easier than taking your medication as a chewable gummy. No fiddling with syringes or packing expensive vaporiser devices.
  
• Dexterity friendly: Since there is no need to grind flower and pack vaporisers, or measure and administer the dose with a tiny syringe, edibles become a lot easier to use for people who have limited dexterity due to age, or other factors like arthritis.
  
• Ease of dosing: Doses are typically in the number of pastilles a patient takes which is much easier to manage, as opposed to an exact millimetre dosage of oil that needs to be measured, or amount of flower to be vaporised and number of inhalations (which can often be inconsistent).
  
• Taste: Unlike most oil products, gummies come in a variety of flavours and have been sweetened, making them vastly more pleasant-tasting to most patients. Most oil products tend to not be artificially flavoured, and so are not necessarily suitable for people who have serious taste-aversion issues.
  
• Long-lasting: The most notable advantage of medicated cannabis edibles, is that they have a much longer duration of action than inhaled cannabis. The effects of edibles can last up to 8-10 hours (depending on individual patients’ metabolism and other variables) making them a great option for long-term ongoing symptom relief.

As you can see, there are many advantages to edible cannabis formulations, making them an appropriate dosage form for a variety of different patients. However, it is imperative we are also clear about the disadvantages of using edibles and where they may not be the most appropriate dose forms.

While the duration of effect of edibles is prolonged, their onset of action is delayed compared to inhalable cannabis. Which means that when quick-acting relief is needed, they are not an appropriate dosing form. 

Another thing to keep in mind is that the delayed onset can lead to patients taking more than instructed, and once the higher dose takes effect, it may be overwhelming (to say the least). It is extremely important that – just like with all medicine – patients start low and go slow.

If you think edibles are an avenue you wish to explore, then talk to your prescribing doctor about whether or not it is an appropriate dosage form for you.

You can also book a call with one of our nurses to learn more.

For many of us, our reproductive health journeys involve navigating not just one diagnosis, but several interconnected conditions that impact our daily lives, fertility, and overall wellbeing.

The reality of multiple diagnoses

The reproductive system doesn’t exist in isolation. Hormonal imbalances or inflammatory processes that trigger one condition can create an environment where other conditions develop or worsen.

If you’ve been diagnosed with endometriosis and then later learned you also have adenomyosis, or if you’re managing PCOS alongside fibroids, you’re not alone. Research increasingly shows that these conditions frequently overlap, creating complex symptom patterns that can be challenging to untangle.

Understanding the connection between Endometriosis & Adenomyosis

Studies suggest that up to a third of women with endometriosis also have adenomyosis. 

While endometriosis involves tissue similar to the uterine lining growing outside the uterus, adenomyosis occurs when this tissue grows into the muscular wall of the uterus itself.

Both conditions:

• Share inflammatory pathways
• Respond to similar hormonal influences
• Can cause severe pain and heavy bleeding
• May impact fertility

PCOS and its reproductive neighbours

Polycystic Ovary Syndrome affects hormone levels, causing enlarged ovaries with cysts. While its primary characteristics differ from endometriosis and adenomyosis, research indicates that women with PCOS:

• May experience more severe symptoms if they also have endometriosis
• Can face compounded fertility challenges when multiple conditions are present
• Often deal with hormonal imbalances that can worsen other reproductive conditions

Fibroids and their friends

Uterine fibroids – benign growths within or on the uterus – are incredibly common, affecting between 40% to 80% of women by age 50. They frequently coexist with other conditions:

• The inflammation associated with endometriosis and adenomyosis may create an environment where fibroids thrive
• Hormonal shifts in PCOS can influence fibroid growth
• When present alongside adenomyosis, symptoms like heavy bleeding and pelvic pain can intensify

The challenge and the future  

One of the greatest frustrations for those with multiple reproductive conditions is the lengthy diagnostic journey. With symptoms often overlapping, it can take significant time to figure out which conditions are present and how they interact. A heavy period might be attributed to fibroids when adenomyosis is also contributing, or pain patterns typical of both endometriosis and adenomyosis might lead to incomplete treatment if only one condition is addressed.

While managing multiple reproductive health conditions presents unique challenges, there’s reason for optimism. Researchers are increasingly studying these conditions not in isolation, but in relation to one another. This holistic approach is already yielding insights that may lead to better diagnostic tools and more effective treatments.

Diagnosis can be a long and lonely journey. By sharing your story, you might help someone still searching for answers—and remind them they’re not alone.

*At Astrid, while we use the term ‘women’ in our endometriosis campaign, we recognise this reflects common but incomplete medical terminology. Endometriosis can affect people across the gender spectrum, and conventional language often fails to acknowledge this reality. We welcome and support all individuals affected by endometriosis, regardless of gender identity. 

Endometriosis has historically been diagnosed through surgery and until recently has been the only way of getting a definitive diagnosis. 

The most common surgical procedure for endometriosis is laparoscopy. This is when a thin telescope is inserted into the belly button to see and access the organs inside the abdomen and pelvis. If the surgeon sees anything abnormal during the procedure, then they can remove this (called a biopsy) and send it to a lab. In the lab they can confirm if the cells in the biopsy are from an endometriosis lesion or not.  This technique using biopsies is still the most accurate form of diagnosis at the moment. 

However there are quite a few drawbacks to using surgery to diagnose including

• Cost – depending on whether you are in the public or private system there can be quite a large out of pocket cost, from a few hundred up to over $10,000 dollars.
• Waiting times – because this is a surgical procedure it can’t be done in private rooms, but requires a hospital visit meaning that there needs to be availability of a surgeon, an anaesthetist, surgical nurses and usually a hospital bed afterwards This means there is often a long wait time – especially in the public system
• Risks – because it’s a surgical procedure it comes with risks getting an infection, major bleeding, and injury to important structures like the bowels or bladder. It also often takes about a month or more to recover from the surgery. 

Because of all of these factors, there has been a big effort to find ways to diagnose endometriosis that is low cost, non (or less) invasive, and low risk. Ideally something that can be done either at a doctors office, or even better, in the privacy of your own home. 

There are a number of different tests that are being developed, from saliva tests, to blood tests, and even vaginal swabs.  Unfortunately, at the moment, while some of these are quite promising, none seem ready for “prime time” usage. To have a good test you need to be able to make sure that people who have the disease get a positive result and those that don’t get a negative result. Getting too many false negatives or false positives can mean the test isn’t very useful and for most of these tests at the moment they are still needing to work on improving this. For example the blood test seems very accurate, but so far can only detect severe endometriosis. 

Over the past ten years or so, there has been an increasing ability to “see” endometriosis using imaging such as transvaginal ultrasound (TVUSS), an internal scan where the ultrasound wand is inserted into the vagina, and magnetic resonance imaging (MRI). While these aren’t able to be done at home, unless you happen to have an MRI machine in your back yard, they are much less expensive than surgery and the wait time is much less. 

It’s important to understand that there are different “stages” of endometriosis – ranging from superficial to deep. While these stages don’t correlate to the amount of pain or other symptoms, it’s usually much easier to “see” endometriosis when there is more of it. Not all types of endometriosis are yet reliably seen on an imaging test. For example, severe endometriosis with deep nodules and adhesions (bands of scarring which can attach to other organs) is easier to see than superficial endometriosis, which sometimes consists of a few deposits no larger than a few millimetres. 

So what this means is at the moment we can use TVUSS and MRI to “rule in” endometriosis. That means if you have endometriosis show up on a scan, we can be quite confident that you do have endometriosis – especially if it shows up with indicators of deep infiltrating endometriosis. But if you have a “clear” scan it doesn’t mean that you don’t have endometriosis. No test is perfect and, especially if you have superficial endometriosis, it can still be hard to spot. But things are improving – especially using new technologies like AI and machine learning. If you have a “clear” scan and have endometriosis symptoms then you should speak to your doctor as you might need to consider having surgery for a diagnosis, because a clear scan should never be taken as being definitive. 

At the moment, while we wait for the holy grail of a very accurate, cheap and non-invasive test, TVUSS is probably the best tool we have at the moment. It can be done in about 30-60 minutes, costs around $500 dollars or so, and you can often get a scan done within a few weeks of having a referral. 

Associate Professor Mike Armour is the Director of Research and an Associate Professor in reproductive health at NICM Health Research Institute, Western Sydney University where he is currently running several clinical trials on endometriosis, menstrual health, and complementary medicine. Mike has published 120 peer reviewed articles on various aspects of women’s health including medicinal cannabis, Chinese medicine and acupuncture. Mike is also an author on several textbook chapters including several on medicinal cannabis for women’s health. Mike has had significant media attention on his work including 15 articles in The Conversation, an SBS Insight special on endometriosis, an SBS special on herbal medicine for period pain and over 300 pieces of international news media with an estimated readership of 80 million across over 100 countries including Channel 7 News, ABC News, and The Guardian.

Mike is heavily involved in research and treatment of endometriosis, and he is the complementary medicine expert on the endometriosis expert working group (EEWG) for the Royal Australia and New Zealand College of Gynaecologists (RANZCOG). Mike is also a World Endometriosis Society Ambassador, Academic lead of the Menstrual Cycle Research Network (MCRN) at Western Sydney University and Chair of the Australasian Interdisciplinary Researchers in Endometriosis (AIRE).

Mike is currently leading the EndoCann trials — a clinical study investigating medicinal cannabis for endometriosis — and is actively recruiting participants. Learn more or sign up here.

The following is an excerpt from Astrid founder Lisa’s chapter in the “Australian Guide to Living Well with Endo” by Maree Davenport.

Last year, my husband and I embarked on our fertility journey. I was diagnosed with PCOS and infertility, but the cause of my infertility was unknown. I know it sounds horrible, but I always knew that I’d eventually have fertility issues – I just knew. Just like how I knew my early childhood period onset was due to my sexual abuse. It is ironic now, after years of helping female patients with chronic pain and female health – that I am on my own female health journey. 

We went to multiple fertility doctors, changing fertility specialists not once, not twice but three times in a span of 12 months. Each time, we were told different things. Each time, we were expected to do another round of IVF. Each IVF round was more injections, more hormones, more pessaries, more blood tests, more tablets. It was exhausting, and there were so many times where I didn’t know if I could keep doing another round. 

My body started to change. The hormones made me gain weight. The doctors thought I was immunocompromised because I have eczema and said I had “increased natural killer cells” so they made me take prednisolone for weeks on end – to the point where my face turned into the shape of the moon (moon face being one of the major side effects of steroid medication). 

My skin got itchy and dry from the constant up and down changes in hormones. I started losing hair, and I’d cry in the shower every time I saw more hair go down the drain. 

I had miscarriage after miscarriage. And each time, the doctors couldn’t give me answers. One of the last phone calls with the nurses – from a clinic that I won’t name – lasted for 3 minutes. She called to let me know that it was another miscarriage and sounded so impersonal and I could feel her ingenuity through the phone – it was like she was reading from a script to fake empathy. I felt numb on the inside by our last failed IVF cycle and last miscarriage – I felt nothing. 

And yet, all the while, I was still running a full on medicinal cannabis business where I wanted to show up for my people, my patients and my community. Thankfully, my colleagues and my team are the most beautiful and supportive people – who gave me space, time and support when I needed it.

A few weeks after my last miscarriage, I was at my cousin’s 18th birthday family BBQ. It was a cold winter Melbourne evening, and in true Vietnamese style, we had every single Vietnamese dish you could think of out in the backyard, buffet style. It was so nice having the family together and it’s certainly one of my favourite things about being Australian-Vietnamese. 

However, what Vietnamese people aren’t very good at is tact. I remember a very core moment that almost broke me – and I believe will stay with me for the rest of my life. I was eating my cousin’s birthday cake, and my uncle came up to me and said: “you shouldn’t eat that, you’re so fat now”. I remember freezing and felt waves of anger, sadness and just defeat overtake me. I brushed it off, because of course, in Vietnamese culture, we’re taught to respect our elders and not talk back. But he kept going: “you should eat less, you’ve gained so much weight”. At this point, my CEO brain switched into gear and I replied calmly and respectfully “I’m just letting you know that I’ve just experienced multiple miscarriages, I’ve just had another IVF failed cycle a few weeks ago and I’ve been on hormonal medication that has caused weight gain”, thinking he’ll back off after I’ve given him a logical response. But he kept going and he didn’t stop. I heard his daughter, my cousin, to my left say “Dad, you’re being so mean”. 

In that moment, I froze. I kept repeating “it’s from the medications”. As the words slipped out of my lips over and over again, I felt so much anger. Anger that I had to even defend myself. Anger that women are expected to bounce back after they’ve lost an embryo, let alone multiple embryos. Angry that there is an expectation for women to look a certain way without regard for what stage of life they’re going through. 

And he kept berating me, and at some point, the strong, respectful, resilient defence I had put on started to crumble, and crumbled quickly. And his hurtful words started to penetrate through my head, morphing with my thoughts of shame, disappointment and sadness. And I spiralled out of control. 

I felt myself breakdown. In my moment of vulnerability, I turned around to grab my husband and I broke down in uncontrollable sobs in his arms. It was the first time I’ve ever cried in front of my big Vietnamese family. After all, for 35 years I’ve been the eldest, driven, strong female niece, cousin, sister and daughter. Everyone was in shock. I didn’t have the strength, in that moment, to confront my uncle or defend myself. I completely froze and crumbled into a heap of helplessness. And it was my beautiful, loving husband that held me in arms in that moment of vulnerability – and defended me in front of my entire family in a moment where I had no fight left in me. 

I think in Vietnamese culture, our elders forget just how much words can hurt, harm and shape a person – especially men speaking to women. In hindsight now, I know my uncle didn’t mean it in a harmful way. He was “just trying to look out for me”. But words and language are so powerful – and it can make or break a human being. When I reflect on this, I think about all the other women in the world who must have been in this same situation. Who come from cultures where you’re taught to be obedient and demonstrate respect and not speak up. We are silenced to the point of trauma. 

Furthermore, at what point is it considered okay to stand up for yourself? To defend your own dignity? Is it after you’ve been sexually abused at nine years old? Is it after rounds of IVF, multiple miscarriages and infertility? Is it in a boardroom full of men in suits when you’re pitching your business to potential investors and they call you a “little girl with great ideas”. But that’s a whole different story for another day. 

Last week, I underwent hysteroscopy and laparoscopy surgery. I found myself a new fertility doctor who is kind, patient and empathetic. And one of the first things she told me when she saw me for the first time was – I can almost guarantee that you’ve got endometriosis, and this is probably the cause of your infertility. 

The surgery went really well and very smoothly – and sure enough, post surgery, my fertility doctor tells me that I’ve had two very blocked fallopian tubes and she’s found some signs of endometriosis. She tells me that my infertility has been environmental i.e. blocked tubes and endometriosis, alongside PCOS – and said now we can try naturally. I felt so happy and so relieved in that moment, I almost cried. Not just because we could try naturally, but simply because we finally have answers. 

And with infertility, half the pain and frustration is just not knowing or no one being able to give you answers and feeling like an experiment. In that moment, speaking to my fertility specialist, and seeing the genuine light and care in her eyes – I felt human again. 

To continue reading about Lisa’s journey, or to read other contributors’, such as Kayla Itsines and Emma Watkins, deeply personal experiences with endo, you can purchase The Australian Guide to Living Well with Endometriosis online or in-store wherever you buy your books. 

Endo isn’t just “bad period cramps”. It’s a complex chronic condition that causes serious pain, fatigue, and other symptoms that can make working difficult. For the 830,000 Australians with endometriosis, small changes in the workplace can make a real difference in managing work and health. Here’s some ways you can make that happen.

Flexible Work Options

Flexibility is crucial for employees managing endometriosis. When pain flares up unexpectedly, having the option to work from home can be the difference between a productive day and a sick day.

• Flexibility to work from home when symptoms flare up
• Flexible working hours
• Permission to take breaks when needed
• Job-sharing options
• Provide staggered or altered return-to-work options for surgery or medical episode recovery

Leave Policies That Work

Thoughtful leave policies demonstrate that your organisation understands the realities of living with endometriosis.

• Establish a menstrual leave policy
• Separate menstrual leave from sick leave
• Offer extra leave for chronic conditions management 
• Do not require a doctor’s certificate
• Make leave easy to request
• Include everyone who needs it
• Consider including time for partners of people with periods too 

Build Understanding

Better understanding makes better workplaces. Invest in educational resources, and provide specialised training for managers so they can appropriately support team members with endo without overstepping boundaries.

• Create a safe working environment
• Help your team learn and understand more about chronic illness and how it can show up in the workplace
• Train managers to support their team appropriately 
• Keep communication open
• Make health chat normal, not awkward

Improve Communication 

Creating clear channels for discussing health needs is essential in an endo-friendly workplace. Establish confidential ways for employees to communicate their needs without having to share personal medical details with everyone.

• Speak to the staff member to understand what they need 
• Make relevant accommodations without fuss
• Be collaborative regarding return-to-work goals post surgery
• Be transparent about any issues  
• Ensure any upper management understands the situation to avoid accidental escalation 
• Make receiving support simple  
• Provide an Employee Assistance Service (EAS) if possible  

Not sure where to get started? There are many small ways you can get the ball rolling on an endo-friendly workplace (or any chronic disease—supporting people with endo creates a better workplace for everyone!). Start the conversation about chronic health conditions in your team. Check your existing policies to see what could be updated. Print out this list and not-so-subtly leave it on your manager’s desk. Even when a step seems small, it’s still a step closer towards providing the flexibility and support that can give someone with endometriosis the best chance to succeed on your team. 

Experiencing office life with endo? We want to hear your story. Share it as part of the Bodies of a Broken System project here. 

_{^{*At Astrid, while we use the term ‘women’ in our endometriosis campaign, we recognise this reflects common but incomplete medical terminology. Endometriosis can affect people across the gender spectrum, and conventional language often fails to acknowledge this reality. We welcome and support all individuals affected by endometriosis, regardless of gender identity.}}

You’re not alone—almost 1 million Australians are sharing this journey with you, and many of us have sat in doctors’ offices searching for the right words to explain what we’re going through. 

This guide will help you translate your experience into terms that doctors can understand and act upon. 

Make your pain scale meaningful 

Doctors often ask you to rate your pain from 1-10. Instead of getting stuck with numbers, try connecting them to your real-life experience to provide the correct context for your doctor. 

Pain level 4-5:
The pain interferes with my daily activities but I can still work through it with regular over-the-counter pain medication. 

Pain level 7-8:
I need to call in sick to work or cancel my plans, and can’t focus on anything else but the pain. Over-the-counter medication barely touches the sides. 

Pain level 9-10:
I need someone to drive me to the emergency room. 

Find the right words

Instead of just saying “it hurts,” here are some words that can help paint a clearer picture for your doctor. 

Stabbing: Sharp, knife-like pain

Cramping: Rhythmic tightening pain

Burning: Hot, searing sensation

Throbbing: Pulsing pain that comes in waves, like a heartbeat of pain

Dragging: Heavy, pulling sensation in the pelvis

Radiating: Pain that spreads from one area to another

Map it out 

Being specific about pain location and patterns can help your doctor to understand your unique experience.

“The pain starts in my lower right abdomen and radiates down my right leg”

“It moves from my lower back to my pelvis”

“Both sides hurt, but my left side feels like it’s getting the worst of it”

Share your daily reality 

Help doctors understand the severity of your experience by explaining how the pain affects your daily activities. 

Consider how your pain affects: 

Work life 

• Are you forced to work from home due to pain?
• How many sick days do you have to use due to symptoms?
• What adjustments do you have to make to work (e.g. heatpacks, wearing a TENS machine to work, carrying a supermarket worth of overnight pads in your work bag)?

Exercise routine

• Does your pain interrupt your exercise routine?
• Have you had to modify or give up certain physical activities?
• Are there times when even basic movement becomes difficult?

Social life and relationships 

• Do you have to cancel plans due to pain?
• Do you miss out on events or trips due to fear of pain flare ups or bleeding through?
• How does your condition affect your relationships with family and friends?
• What impact does it have on your ability to make and keep social commitments?

Intimacy

• Do you experience painful intercourse?
• Do you anticipate pain, which leads to a decrease in desire? 
• Do you experience pain spasms during intercourse? 
• Do you bleed after intimacy?

Financial impact

• How much money goes towards pain medication?
• Do you have to take unpaid time off work?
• What ongoing medical expenses do you have?
• How does this condition affect your financial security?

Track changes and patterns

Document how your pain changes. Keep a record of: 

Time of day: “The pain is worst in the mornings”

Cyclical patterns: “My pain intensifies during ovulation and menstruation”

Triggers: “My pain flares up after eating certain foods or during physical activity”

Highlight associated symptoms

Pain often brings along some unwelcome friends. Let your doctor know about other symptoms that occur with your pain, such as:

• Fatigue
• Nausea
• Heavy bleeding
• Bowel changes
• Bladder issues

Be specific about what helps and what doesn’t 

Being honest about your pain management helps your doctor understand what you’re dealing with. 

“Regular painkillers barely touch the sides”

“Heat packs only provide temporary relief”

“There are times when all I can do is just lie still and wait it out”

Tips for your doctor’s visit

• Keep a pain diary prior to your appointment as a record of your experience 
• Write down your main points and what you want to say—it can be hard to remember everything
• Consider bringing a support person who can help advocate for you
• Don’t downplay your symptoms—be honest about their impact
• If possible, book a longer appointment to ensure you have enough time for discussion

For more information on how to advocate for yourself at the doctors, read our blog written by RN & Astrid Health Clinical Manager Olivia Lackmann. 

When to seek emergency care

You know your body better than anyone. Here’s how to know when to head to an emergency room:

• Severe, uncontrolled pain that’s different from your usual endo pain
• Heavier-than-usual bleeding that soaks through a pad every hour
• Severe nausea and vomiting
• Signs of infection like fever
• Difficulty urinating or having bowel movements

Most importantly, remember that your experience is valid, your pain is real, and you deserve care that takes you seriously. Being able to tell your story clearly is a powerful step toward getting the support you need. You don’t have to figure this out alone. 

Women’s* health and pain have been minimised, misunderstood, and misdiagnosed in medical settings for too long. Despite significant advancements in medicine and healthcare technology, countless women with endometriosis, PCOS, fibromyalgia, and other conditions continue to struggle for proper diagnosis and effective treatment.

Many women report feeling unheard or undertreated in the healthcare system. When they report pain, they’re too often met with skepticism rather than solutions—told their symptoms are “just stress,” “all in your head,” or simply part of being female. 

This systemic failure doesn’t just represent a gap in care; it fundamentally diminishes quality of life, erodes mental health, and perpetuates a cycle where suffering is normalised rather than treated.

Challenging medical bias

Female pain has historically been sidelined in medical research and clinical practice, too frequently labeled as “emotional,” “hormonal,” or “exaggerated.” This dismissal leads to troubling consequences: years-long diagnostic delays, inadequate treatment protocols, and unnecessary suffering.

Here’s how you can advocate effectively for better care:

Speak up about your experience
Share your experiences openly—with healthcare providers, support groups, and on social media. Share your story, connect with others, and help raise awareness about the challenges women face in getting proper pain management. 

Stay informed and ask questions
Research your symptoms thoroughly, document your pain patterns, and come prepared to appointments with specific questions. If a provider dismisses your concerns, don’t hesitate to seek second or third opinions. 

Support research and policy change
Support organisations researching women’s health conditions, sign petitions for increased research funding, and contact elected officials about healthcare equity legislation. Individual advocacy combined with collective action creates powerful change.

Your pain isn’t imaginary, exaggerated, or something to endure silently. You deserve healthcare that takes your symptoms seriously and pursues effective treatment with urgency and respect.

The expanding role of natural therapies in women’s pain management

As more research emerges, natural therapies are being better recognised as a treatment option for women’s health issues where conventional therapies may not have been effective. 

The phytocannabinoids found in cannabis plants work by interacting with the body’s endocannabinoid system—a complex network that helps regulate pain perception, inflammatory responses, and mood stabilisation. For many women, these natural alternatives offer meaningful relief with potentially fewer severe side effects than conventional analgesics like opioids, providing a valuable option when first-line treatments haven’t delivered adequate results.

Natural therapies (CBD and THC containing medicines) are gaining recognition as a pain management tool for women’s health conditions, like endometriosis, where conventional first-line therapies have not been effective. Some common dosing formats include:

• Oils and edibles: Longer-lasting effects, but have slower onset.
• Wafers: Quicker acting than oils/edibles, avoiding vaporisation, can be another effective option for breakthrough pain. 
• Topical and PV creams: Can be useful for cyclical pelvic pain.
• Vaporisation: Offers quicker relief for breakthrough pain.

Natural therapies may also help address other conditions women with chronic pain can experience, including sleep disorders, and mental health issues.

In addition to their direct pain-relieving properties, natural therapies may also help reduce reliance on pharmaceutical painkillers, including NSAIDs and opioids. Many women seek alternative options due to concerns over side effects, long-term dependency, or medication resistance. 

A discussion with a specialised doctor is important. A medical professional with expertise in natural therapies can develop a personalised treatment plan tailored to your specific needs, ensuring your care is safe and effective.

Final thoughts

Women deserve better recognition and treatment of their pain. The stigma surrounding women’s pain and alternative natural treatments is slowly changing, but there is still work to be done. If you’ve faced challenges in pain management, know that you’re not alone, and that your voice matters in the fight for better women’s health care. 

If you’re curious about natural therapies, you can organise a complimentary nurse chat with the Astrid team. 

OLIVIA LACKMANN

Olivia Lackmann is Astrid Health’s Clinical Manager, and a Registered Nurse with experience in specialty surgical nursing, palliative care, and general practice. Olivia is committed to guiding and supporting patients in achieving better wellness. She has spoken with hundreds of women suffering from debilitating chronic conditions like endometriosis, adenomyosis, and PCOS, and has gained valuable insight into their stories, experiences and treatment outcomes. 

_{^{*At Astrid, while we use the term ‘women’ in our endometriosis campaign, we recognise this reflects common but incomplete medical terminology. Endometriosis can affect people across the gender spectrum, and conventional language often fails to acknowledge this reality. We welcome and support all individuals affected by endometriosis, regardless of gender identity.}}

Managing endometriosis is often as much about emotional wellbeing as it is about physical symptoms. Here’s why maintaining boundaries that help preserve your energy and protect your mental health are so important. 

I think the ‘Spoon Theory’ offers a really useful metaphor to help us think about the experience of living with a chronic illness like endo, particularly how our energy and resources are limited so need to be carefully managed.  

In the theory, spoons represent units of energy. A person in full health might wake up with an unlimited number of spoons, whereas someone with a chronic illness wakes up with a set number, and every activity they do—getting out of bed, having a shower—uses a spoon. Once they’ve used all of their spoons, they’ve used all their energy for the day (and can go into a spoon deficit).

The Spoon Theory helps us to understand why setting boundaries and being intentional about where we allocate our ‘spoons’ (and where we don’t) is so important for our mental and physical health. It can also be helpful when trying to communicate to others that we have limits to how much we can do and take on. 

But first, what exactly are ‘boundaries’? Boundaries are like personal limits or guidelines that individuals set in order to take care of themselves—emotionally, mentally, and physically. Think of them like protectors, guarding your energy and mental health. These limits include how much energy you give to certain things (e.g. people, work, social media) and what you say ‘no’ to that would use too many ‘spoons’. 

The benefits of maintaining boundaries around your energy and mental health include: 

• Conserving your energy for what matters most to you
• Prioritising your health and wellbeing needs
• Being more in tune with your mind and body 
• Avoiding overwhelm, burnout, anxiety and depression
• Feeling empowered and more in control
• Maintaining healthier, more supportive relationships 
• Feeling more balanced and centred within yourself
• Better management of pain and symptoms 

But setting and maintaining boundaries isn’t always easy. It can be difficult to say ‘no’, express our own needs and priorities, and risk potential conflict or disapproval from others. The good news? With awareness, support and practice, setting boundaries is a skill that can be learned. In fact, I’ve seen clients who have struggled with boundary-setting grow into very confident boundary setters. 

Here are some tips for setting and maintaining healthy boundaries around your energy and protecting your mental health:

• Remind yourself that you are the expert on your body and your life, and only you know what your limits are (and what the consequences are if you go beyond them).
  
• Try to view your boundaries as preventative healthcare; like exercise or diet. Remember, rest is proactive and productive!
  
• Be simple and concise in your communication with others, resisting the need to over-explain or justify your decisions or needs to everyone. Try communicating your limits as if they are any other ‘neutral’ statement. Like “thanks for the invite but I’ve already got something on earlier that day so I’ll need to rest”.
  
• Try to surround yourself with supportive, understanding people who respect your boundaries. It’s okay to distance yourself or let go of relationships that feel draining or people who invalidate your experience. Sometimes there will be people who don’t like it when you start to set boundaries. This is when it’s helpful to return to your ‘why’—you don’t have an unlimited supply of spoons, and you need to prioritise where you use them so you can feel the best you can.
  
• Work on becoming comfortable with saying ‘no’. Sometimes we can be conditioned to think saying ‘no’ is selfish, but it’s actually an act of self-respect and self-care. If you know you find saying ‘no’ difficult, and tend to prioritise others’ needs and wants ahead of your own, it may be helpful to reflect on why this might be. Sometimes when we better understand where a roadblock is coming from, we can better navigate around it. And remember that it’s okay to start small. Practice saying ‘no’ in low stakes situations, like ‘no’ to more cake at a party, and build your confidence from there. Having a personal ‘no’ script ready to go can also help take the pressure off in the moment. Something like ‘I can’t take on anything else right now’ can apply to lots of different situations.
  
• We often think of boundaries as something that relates to how we interact with the external world, but it’s just as important to develop and maintain healthy mental boundaries. This might look like challenging perfectionism and unrealistic expectations of what you ‘should’ be able to do, by replacing self-critical thoughts with self-compassionate ones. Or noticing that when we scroll on social media for too long, it depletes us of energy or negatively affects our mental state, so we set boundaries around the amount of time or energy we give to it.

Setting and maintaining boundaries is not just a way to protect your energy and mental health, but a powerful act of self-respect that can help you feel more in control and empowered, and enable you to navigate life with endo with more confidence.    

ANGIE MASHFORD-SCOTT 

Angie is a counsellor and therapist specialising in mental health care and support for those with endometriosis. Angie believes that individual support must work in tandem with broader advocacy and awareness-building to create meaningful change. Along with the launch of the endokind podcast this March, she actively collaborates with other change-makers in this space and serves as a leading member of the International Endo Violence Collective. 

www.endokind.com.au

IG: @endokind_au

What IS endometriosis?

In simple terms, endometriosis is when tissue similar to your uterine lining decides to go rogue and grow places it absolutely shouldn’t—ovaries, fallopian tubes, intestines, and sometimes even lungs or other far-flung locations. Unlike your regular period tissue that has an exit strategy, this stuff has nowhere to go. It causes inflammation, forms scar tissue, and can make life very painful for the person it’s growing in. 

Unfortunately, endometriosis remains widely misunderstood, misdiagnosed, and mistreated within healthcare systems worldwide. Patients are often left to navigate a web of complex misinformation.

So, if you’ve ever been told “it can’t be that bad” or to “pop a painkiller and push through”, this blog is for you. 

Let’s cover some of the most common myths and misconceptions about endometriosis. 

Myth 1: It’s just bad period pain

This dismissal of pain as a normal part of menstruation represents both a medical failure and a cultural problem that needs addressing. Many endometriosis patients report being told from a young age that severe period pain is something they simply have to endure. 

While mild discomfort during menstruation isn’t unusual, pain that interferes with daily activities, causes vomiting, or requires strong pain medication is NOT normal. Endometriosis pain differs from typical menstrual cramping, and can occur all throughout the month, not just during periods; and can occur throughout the body, not just in and around the pelvis. 

Myth 2: It’s all in your head 

Endometriosis is a physical disease with clearly observable pathology. While chronic pain can certainly affect mental health, the pain itself stems from biological processes including inflammation, nerve irritation, and organ dysfunction.

The psychological dismissal of physical pain has a long history in women’s healthcare. Endometriosis patients frequently report being told their symptoms are psychosomatic, anxiety-induced, or exaggerated. Some are referred to psychiatrists rather than gynecologists, prescribed antidepressants instead of pain management, or simply told to “reduce stress.”

Nothing says “medical misogyny” quite like telling someone their very real physical pain is just their imagination running wild. This dismissal doesn’t just delay diagnosis—it makes people doubt their own experiences and hesitate to seek the care they desperately need.

Myth 3: Pregnancy will cure endometriosis

Ah, the classic “use a whole human being as a treatment plan” approach. Not only is this advice wildly inappropriate (babies aren’t medicine, folks!), it’s also just flat-out wrong.

While pregnancy might temporarily suppress symptoms for some people thanks to hormonal changes, endometriosis can come roaring back after delivery. Plus, many with endometriosis struggle with fertility in the first place, making this advice extra salt in the wound.

Myth 4: A hysterectomy will cure endometriosis

“Let’s just take out your uterus.” Hysterectomy (surgical removal of the uterus) is often presented as a definitive cure for endometriosis. And the hysterectomy solution gets tossed around like it’s no big deal. 

But since endometriosis, by definition, occurs outside the uterus, removing the uterus alone will not eliminate the disease or its symptoms. While some patients experience symptom improvement after hysterectomy with oophorectomy (removal of ovaries), which reduces estrogen that can fuel endometriosis growth, it’s not a guaranteed cure. 

Myth 5: Menopause will cure endometriosis  

Allegedly, when your hormones change and periods stop, endometriosis magically disappears! Except… it doesn’t work that way for everyone. While some people do experience relief after menopause (natural or surgical), many continue to have symptoms. Those pesky endometriosis implants can still cause inflammation and pain even without the monthly cycle triggering them. Not to mention that hormone replacement therapy, which many use to manage menopause symptoms, can actually stimulate endometriosis lesions and bring back symptoms.

Plus, being told to just suffer through potentially decades of pain until menopause arrives? That’s not a treatment plan—that’s a sentence.

Endometriosis is not simply “bad periods”—it’s a complex, whole-body inflammatory condition that deserves proper attention, research, and treatment. The current state of care reflects deeper cultural issues in medicine that harm real people every day. For now, we can speak up about our experiences, support endo research, and share the realities of life with endometriosis to help others truly understand the endo experience. 

We want to hear about your lived experience with endo. Share your story here and help us point the spotlight on endometriosis.

Living with endometriosis can be overwhelming. The pain, fatigue, and other symptoms can make day-to-day life tough. While medical treatments like surgery and hormones are important, many people find that adding natural approaches helps them feel better overall. That’s where Naturopathy comes in.

Naturopathy can be a key part of a holistic care plan, focusing on diet, herbal medicine, and lifestyle strategies that may help manage inflammation, hormonal imbalances, and gut health—key factors in endometriosis symptom management. 

This guide shares practical naturopathic strategies that can work alongside your regular treatment plan. 

Key factors contributing to endometriosis symptoms

Liver Support

The liver plays a crucial role in hormone metabolism, including breaking down and eliminating excess oestrogen, which can contribute to endometriosis symptoms.

How naturopaths help: Using specialized herbs and nutritional support to enhance liver detoxification pathways, helping your body more effectively process and eliminate excess hormones that may be driving symptoms.

Gut Health Optimization

Studies suggest that gut bacteria and inflammation can significantly influence endometriosis symptoms. Lipopolysaccharides (LPS) found in the gut have been linked to increased inflammation in endometriosis patients.

How naturopaths help: Prescribing specific herbs, probiotics, and dietary recommendations to promote a healthy gut microbiome and reduce inflammatory triggers.

HPO Axis Regulation

Endometriosis is an oestrogen-dominant condition, and disruptions to the HPO (hypothalamic-pituitary-ovarian) axis can further impact hormone balance. Naturopaths may use herbs and nutritional support to help regulate this system and promote hormonal equilibrium.

How naturopaths help: Using targeted herbs and nutritional supplements to help regulate this important hormonal system and promote better hormonal equilibrium.

Anti-Inflammatory Support

Chronic inflammation is a key driver of endometriosis pain and progression.

How naturopaths help:

• May recommend a diet rich in anti-inflammatory foods such as omega-3s, turmeric, and ginger
• May recommend avoiding highly inflammatory foods like processed sugars, dairy, and gluten
• Suggesting herbal remedies to naturally reduce inflammation

Lifestyle tips for endometriosis

Beyond naturopathy, these lifestyle changes can make a significant difference. 

Eliminate BPA Plastics

Long-term exposure to plastic particles, especially those containing BPA, can contribute to hormone disruption. Since endometriosis is a hormone-driven condition, switching to BPA-free alternatives is essential.

Seek Pelvic Floor Therapy

Pelvic physiotherapy can help relieve pain by addressing muscle tightness and dysfunction in the pelvic floor—issues often experienced by those with endometriosis.

Track Your Cycle

Tracking your cycle can help identify symptom patterns and triggers throughout your menstrual cycle, allowing for more proactive management strategies. 

Build a Support Network

Endometriosis can take a significant toll on mental health, contributing to anxiety and depression. Finding a supportive network or working with a psychologist can be invaluable for your mental wellbeing.

The power of a combined approach to care 

Naturopathy works best as part of your overall care plan, not as a replacement for medical treatment. Many of our patients find that combining conventional medicine with these natural approaches gives them better symptom control and improved quality of life. Every person with endometriosis is different, so what works for one might not work for another. The key is finding the right mix of treatments that works for your unique situation.

Want to try a holistic approach to your endometriosis care?

If you’re interested in exploring a naturopathy consultation, you can book a consultation with Georgina Phin here, or organise a free nurse chat with an Astrid team member to see if naturopathy may be right for you. 

GEORGINA PHIN 

Georgina is a clinical Naturopath who holds a Bachelor of Health Science (Naturopathy). She grew up in Melbourne, and now resides on the South Coast of New South Wales. Georgina has experience working in compounding pharmacies, as well as consulting roles in clinical practice. She is very passionate about educating patients on the gentle practice of Naturopathy, and the many benefits of natural therapies. She also loves being able to collaborate with practitioners of other modalities to give patients positive outcomes and reach their health goals. Georgina is particularly interested in assisting patients with their reproductive and mental health concerns, as well as supporting patients with chronic pain, and offering education on general wellbeing and nutrition. 

$31,000 AUD. That’s the average cost Australian women* with endometriosis incur per year, according to a 2019 study by Western Sydney University. This substantial figure encompasses not just direct medical expenses, but also lost work productivity, alternative therapies, pain relief accessories, and mental health support. 

This figure is echoed in personal accounts, such as those shared on QENDO’s What It Cost Me series, where patients highlight not just medical fees but the overall expenses associated with managing the condition.

For the estimated 830,000 Australian women living with endometriosis, the question becomes not just about managing the condition, but doing so in a financially sustainable way. 

Let’s explore the three main avenues available: public healthcare, private treatment, and the emerging option of medical tourism.

The Public System: Free but Slow

The Australian Government recently announced an expansion of Endometriosis and Pelvic Pain Clinics nationwide as part of the National Action Plan for Endometriosis, aiming to reduce diagnosis timeframes and improve access to care.

Pros:

• Free treatment through Medicare
• Access to new Medicare-funded MRI scans
• Part of the National Action Plan for Endometriosis

Cons:

• Extended wait times
• Limited choice of specialists
• Resource constraints

The Private Route: Faster but Costly

Private healthcare offers quicker access to specialists and a wider range of treatment options. However, it comes with a hefty price tag.

Pros:

• Reduced waiting periods
• Choice of doctors and hospitals
• Better access to comprehensive scans

Cons:

• Higher out-of-pocket costs
• Variability in coverage
• Potential for additional charges for tests and procedures

The Medical Tourism Option: Another Perspective

For those willing to look beyond Australian shores, medical tourism presents an intriguing alternative. Countries like Singapore, Thailand, Romania, US, India offer advanced endometriosis treatments.

Pros:

• Potentially lower costs than Australian private care
• Access to international specialists and cutting-edge treatments
• Shorter wait times

Cons:

• Risks with follow-up care
• Potential language and cultural barriers
• Travel costs and logistical challenges

There are various reasons one might consider going international in their search for medical care. From financial constraints to timely access to the latest treatments, many women with endometriosis are exploring medical tourism. 

The Wellborn Network in Bucharest, Romania, led by Dr. Mitroi Gabriel, has gained attention among endometriosis patients worldwide. With many Romanians fluent in English, communication barriers are minimised for Australian patients.

Sample Treatment Costs (As of February 2025)

Procedure	Price ROM	Price AUD
Laparoscopic treatment of stage I-II endometriosis	10,390.00	3,430.67
Laparoscopic treatment of stage II-III endometriosis without digestive/urological resection	12,950.00	4,275.46
Laparoscopic treatment of stage III-IV endometriosis with digestive resection	32,650.00	10,778.17
Excision of parietal endometrioma	7,850.00	2,591.23

*Note: Prices are based on the exchange rate of 1 RON = 0.3301 AUD (as of February 21, 2025). These rates are subject to change, and additional costs for travel and accommodation may apply. This article is not affiliated with any medical provider and is intended for informational purposes only. Always consult with a healthcare professional before making any decisions. Treatments are individualised and you might need other procedures not covered by this list.

Making an informed decision

Ultimately, the best choice depends on your individual circumstances, including the severity of your condition, financial situation, and personal preferences. Consult with healthcare professionals, do thorough research, and consider participating in endometriosis research studies to contribute to future advancements in care.

The journey with endometriosis may be challenging, but with expanding options and ongoing research, there’s hope for better, more accessible treatment for all affected women.

A snapshot of considerations

	Public Healthcare	Private Healthcare	Medical Tourism
Cost	Free treatment through Medicare	Higher out-of-pocket costs	Potentially lower costs, but varies by country
Wait times	6-8 years average for diagnosis	Shorter waiting times for specialist appointments	Generally shorter wait times
Choice of doctors	Limited choice of doctors	Choice of doctors and hospitals	Access to international specialists
Access to advanced diagnostics	Access to new Medicare-funded MRI scans	Better access to comprehensive scans, but with cost gaps	Varies by country and facility
Treatment options	Part of the National Action Plan for Endometriosis	Access to a wider range of treatment options	Possible access to treatments not available in Australia
Continuity of care	Consistent follow-up within the public system	Consistent follow-up with chosen specialist	Challenges with follow-up care after returning home
Language and cultural considerations	Services in local language and familiar culture	Services in local language and familiar culture	Potential language barriers and cultural differences
Insurance coverage	Covered by Medicare	Covered by private health insurance (with gaps)	May not be covered by Australian insurance
Travel requirements	Local treatment	Local treatment	International travel required
Legal protections	Australian medical and legal system	Australian medical and legal system	Varies by country, potentially limited recourse

Meanwhile, your life is on hold—relationships strained, career opportunities missed, and simple joys of life overshadowed by relentless pain. 

You’re not alone, and more importantly, you’re not imagining things. Unfortunately, the history of endometriosis care is deeply intertwined with medical misogyny.

What is medical misogyny? 

Medical misogyny refers to the systemic bias and discrimination against women within healthcare systems. It’s not just about individual doctors with outdated views—it’s embedded in medical education, research priorities, clinical guidelines, and healthcare delivery. This bias manifests as women’s symptoms being dismissed or psychologised, their pain undertreated, their conditions underresearched, and reproductive concerns being considered ahead of their quality of life. 

Medical misogyny isn’t always conscious or intentional; it’s often the result of longstanding cultural attitudes and knowledge gaps that have been institutionalised within medical practice.

Medical misogyny is nasty, but it’s very real—and it’s affecting the rate at which women’s medical care can advance.

Here’s how it’s manifesting in our medical system today.

The Pain Bias

Studies consistently show women wait longer in emergency rooms, receive less pain medication, and are more likely to have physical pain symptoms attributed to mental health issues. Women’s pain is, statistically, taken less seriously than men’s. In fact, women are more likely to be prescribed psychotherapy rather than pain medication compared to men presenting with identical symptoms. For endometriosis patients, this translates to years of having legitimate pain dismissed, undertreated, or attributed to psychological causes.

Research Funding Gap

Endometriosis affects roughly as many people as diabetes, yet receives a fraction of the research funding. This disparity shows exactly how conditions primarily affecting women rank on the medical priority list (spoiler: not high). 

The “Fertility-First” Approach

Some of us just want to exist without pain, regardless of our reproductive plans. But traditional endometriosis treatment focuses heavily on preserving fertility, even for patients who have zero interest in having children, rather than addressing pain and quality of life.

The system should place the person above the potential of a person, but some endometriosis patients are turned away from surgical options as “they might want children later”. While fertility concerns are very valid for many endo-warriors, the assumption that every woman’s main concern is baby-making is both outdated and harmful. It reinforces the problematic notion that a woman’s primary value lies in her reproductive capacity. 

Diagnostic Delays

Imagine if men had to wait 7-10 years for a diagnosis while a condition progressively damaged their organs. There would be protests! Public outrage! Special task forces! Yet, for endometriosis patients, this wait time is a reality. It’s a systemic failure that simply wouldn’t be tolerated for conditions predominantly affecting men. These delays allow the disease to progress, often leading to more severe symptoms, additional organ involvement, and decreased treatment effectiveness. 

Where do we go from here? 

• Medical education reform is needed
  Medical professionals-to-be need better training on recognising symptoms early, understanding the varied presentations, and taking patients seriously from day one. The current “one lecture on endometriosis” approach clearly isn’t cutting it.
  
• Don’t let ‘The Man’ get you down
  If you’re dealing with symptoms and getting nowhere, trust your gut. Document everything. Find doctors who listen (they do exist!). Connect with support groups online where others understand what you’re going through. You are your own best advocate.
  
• Demand better research
  We need more funding, more studies (like the EndoCann Clinical Trial from Astrid and Western Sydney University), and more options beyond “hormonal birth control or surgery.” Period. (Pun absolutely intended.)
  
• Change the conversation, change the cultural attitude
  The normalisation of menstrual pain and the dismissal of women’s health concerns are cultural issues that extend beyond medicine. So let’s stop normalising period pain. Let’s talk openly about symptoms. Let’s teach young people about what’s normal and what’s not. The sooner we stop accepting suffering as inevitable, the sooner we can change the system.

Perhaps the most radical act in a system steeped in medical misogyny is simply this: believing women when they say they’re in pain.

Medical misogyny and gender bias shapes our healthcare experiences, research priorities, and treatment approaches. Your pain isn’t just physical; it’s the result of systemic failures that have consistently pushed women’s health concerns to the periphery of medicine.

But here’s the thing about systems: they can change. They must change. And that change begins with each of us refusing to accept the status quo.

Your story matters. Your experiences are evidence of a broken system that needs fixing. By sharing them, you help create the momentum needed for real, lasting change in how endometriosis—and all conditions affecting women—are approached.

Submit your story to the Bodies of a Broken System project, and add your voice to the growing community demanding better care, better research, and better outcomes for all of us.

If you have endometriosis, you have probably already encountered how frustrating and isolating it can feel when pain interrupts intimacy. Sex becomes something to endure, and the anxiety around it can make even the idea of being sexual feel overwhelming.

Pain during sex is common in people with endometriosis, but it is not something you should just tolerate. Pain tells your body that something is wrong and when you ignore that signal, your nervous system learns that sex is something to be feared, and perhaps even avoided. Over time, this can create a cycle where even the thought of sex triggers anxiety, making penetration more painful due to muscle tension and reduced arousal. 

The pain is your body’s way of saying; I don’t feel safe doing this. And if sex doesn’t feel safe, pleasure isn’t going to happen.

The psychological side of pain and sex

Anxiety is a very common response to pain. Anxiety about pain can make it difficult to relax, which in turn makes pain worse. You might start avoiding sex – or any kind of touch – completely, worrying that it will lead to discomfort or disappointment, and this can create real distance in our relationships. 

And that’s where pressure comes in – the ultimate desire killer. The pressure to “perform,” to be a “good partner,” to meet expectations (yours or someone else’s). But sex isn’t a duty, and your pleasure matters just as much as anyone else’s. If penetrative sex is painful, it doesn’t mean your sex life is over. It just means it’s time to expand what sex means to you.

Expanding the sexual menu

Sex does not equal penetration. I’m going to say that again, just to make sure you don’t miss it! Sex does not equal penetration. We live in a world that centres a very heteronormative, penetrative idea of what sex is. But I truly believe sex to be a subjective term; I define for myself what counts as sex, and I invite you to do the same. 

Sex is a broad range of intimate, physical and emotional expressions of eroticism and sexuality, and in fact, some of the most pleasurable and intimate experiences don’t involve penetration at all. When you broaden your definition of sex, you open up a world of connection and pleasure that works with your body rather than against it.

Here are some ways to explore pleasure without penetration:

• Outercourse: Oral sex, mutual masturbation, grinding, and other forms of external stimulation can be just as fulfilling as penetration.
• Sensory play: Focus on different sensations – massage, temperature play, or exploring different textures to create a full-body experience.
• Erotic massage: Not just relaxing, but also a way to foster intimacy and tune into what feels good for you.
• Sexual communication: Talking about desires, boundaries, and preferences can be incredibly arousing and deepen intimacy.
• Using toys: Regardless of whether you can tolerate some penetration or not, there are toys available to you to help you explore pleasure of all kinds.
• Building arousal gradually: Allowing time for full arousal can make a huge difference, and it maximises the chance for our muscles (and mind) to fully relax.

All of these strategies can help you to maximise relaxation and minimise pain, which is going to go a long way to increasing the odds of you accessing pleasure.

Managing anxiety around sex

If anxiety around sex has built up due to pain, it’s important to acknowledge that and work with it rather than against it. Some ways to manage this include:

• Mindfulness and breathing techniques: Learning to calm your nervous system before and during intimacy can help reduce tension.
• Pacing yourself: Give yourself permission to stop if something doesn’t feel right. You are allowed to slow down, adjust, or change course entirely.
• Communication: If you have a partner, talk about your fears and needs openly. The more informed and supportive they are, the safer and more connected you’ll feel.
• Therapeutic support: Working with a sex therapist who understands pain conditions can be transformative. They can help you untangle the psychological impact of pain and build a sexual relationship that works for you.
  

Reclaiming pleasure on your terms

Living with endometriosis means that sex might not look the way it once did – or the way mainstream media tells you it should look. But by shifting the focus from ‘pushing through’ to tuning in, you can have a pleasure-filled and fulfilling sex life. 

By honouring your body, expanding your idea of what sex can be, and managing anxiety with self-compassion, you can create a sex life that feels both pleasurable and safe. 

Your body deserves care, your pleasure is valid, and sex should feel good for you, too!

LAURA LEE 

Laura is a psychologist & sexologist who works at the intersection of all things sex, relationships and mental health. Laura provides individual and relationship therapy and coaching to help people to explore, enjoy and embrace their sexuality. 

www.lauralee.com.au

IG: @lauraleesexology